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Thymic epithelial cells (TECs) are indispensable for the development of T cells in 
the thymus. Two subtypes of TECs exist in the thymus, medullary mTECs and 
cortical cTECs. Both mTECs and cTECs originate from endodermal thymic 
epithelial progenitor cells (TEPCs) in the embryo, but how the differentiation of 
TEPCs is regulated is not well understood. The aims of this thesis were to establish 
the role of Notch signalling in TEPC differentiation, and how it interacts with known 
regulators such as FOXN1 and the NFκB pathway. Gene expression data showed that 
Notch is active in TEPCs and exhibits a correlation with the mTEC lineage. Loss of 
Notch function led to a significant reduction in the number of mTECs in the thymus, 
and this can be attributed to aberrant mTEC specification. Furthermore, the duration 
of Notch activity in determining mTEC number appears limited to the early phase of 
organogenesis, and precedes RANK/NFκB mediated mTEC proliferation. Gain of 
Notch function resulted in a considerable shift to a primitive, TEPC-like phenotype, 
and subsequently a latent increase in mTEC frequency. Finally, transcriptomic and 
functional analyses pointed to a cross-repressive mechanism between Notch and 
FOXN1 in TEPCs. Taken together, these results identified Notch as a novel regulator 
of mTEC specification, likely through maintaining the potency of fetal TEPCs, a pre-











T cells comprise an important part of the immune system. The development of T 
cells in the thymus is controlled by thymic epithelial cells (TECs). TECs can be 
broadly divided into those residing in the cortex (cTECs), and those in the medulla 
(mTECs). The role of cTECs is to select for T cells that are capable of recognizing 
antigens, whereas mTECs are responsible for preventing T cells that can harm one’s 
own tissues from entering the bloodstream. It is known that cTECs and mTECs 
originate from a common progenitor population in development, but how these 
progenitors decide to become either cTECs or mTECs is not well understood. The 
aim of this thesis was to investigate whether a cell-to-cell communication 
mechanism, known as the Notch signalling pathway, is involved in controlling the 
cell fate decision of early TECs. By removing a key component of the Notch 
pathway, or by treating embryonic thymus with a chemical that prevents Notch 
signalling, I showed that Notch is required for the emergence of mTECs. 
Furthermore, using a genetic system that activates Notch signalling in all developing 
TECs, I concluded that Notch facilitates cell fate regulation by promoting the 
maintenance of TEC progenitors. High throughput gene expression analysis 
identified several potentially significant target genes, and demonstrated that Notch 
activity in developing TECs is self-reinforcing. Incorporating the results obtained 
from these work, I proposed an updated model for TEC progenitor differentiation by 
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Chapter I: Introduction 
 
1.1 The thymus 
T lymphocytes develop exclusively in the thymus (Male et al., 2013). In mammals 
the thymus is a bi-lobed organ situated above the heart (Miller, 1961). The organ is 
found in all jawed vertebrates (Boehm and Swann, 2014), reflecting the increased 
complexity in the vertebrate adaptive immune system. The complexity of cellular 
and molecular interactions during T cell development is also highlighted by the fact 
it is the only haematopoietic lineage that requires a dedicated organ. 
The purpose of thymopoiesis is to generate a T cell receptor (TCR) repertoire 
capable of engaging self major histocompatibility complexes (MHC) that display 
foreign but not self antigens (Male et al., 2013). The need to acquire sufficient TCR 
specificities to recognize an immense range of foreign antigens presents a formidable 
challenge to the immune system. Random rearrangement of the TCR loci ensures 
that a diverse repertoire is generated (Krangel, 2009), with the compromise that such 
process is highly energetically expensive: more than 99% of T cells undergo cell 
death during positive and negative selection (Krueger et al., 2017). Defects in 
establishing the thymic microenvironment result in T cell immunodeficiency (Nehls 
et al., 1996), whereas failure to eliminate self-antigen recognizing T cells can cause 
autoimmunity (Kajiura et al., 2004).  
Developing T cells, or thymocytes, account for more than 99% of the cells in the 
adult thymus, with the other 1% composed of various cell types of the stroma (Gray 
et al., 2006). The cells making up the stroma are thymic epithelial cells (TECs), 
dendritic cells (DCs), endothelial cells, fibroblasts, macrophages, natural killer cells 
and thymic B cells (Figure 1.1A). Of these, TECs are of central importance, since 
fully functional thymi can be formed from grafts whose potential stromal 
contribution is restricted to TECs (Gordon et al., 2004). Unlike most types of 
epithelial cells, TECs form neither simple nor stratified epithelium. Rather, they lack 
apparent apico-basal polarity and form three-dimensional reticular meshwork that 
maximizes contact area with thymocytes (van Ewijk et al., 1999).  
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The interior of the thymus is divided into two major regions, known as cortex and 
medulla, through which thymocytes migrate in a highly stereotypical fashion to 
encounter unique signals at each stage of their development (Blackburn and Manley, 
2004). The two compartments contain two subtypes of resident TECs, cortical TEC 
(cTEC) and medullary TEC (mTEC). Localization aside, the distinction of cTEC and 
mTEC also concerns their functions and developmental lineages (reviewed in 
Takahama et al., 2017). The area where outer cortex meets inner medulla is termed 
cortico-medullary junction (CMJ) and has characteristic histological and molecular 
features. It has been shown that certain TECs located at the CMJ exhibit progenitor 
activity (Klug et al., 1998; Ulyanchenko et al., 2016; Wong et al., 2014).  
Perhaps related to the metabolically expensive nature of thymopoiesis, or the 
selective pressure to minimize cancer risks, the thymus begins to degenerate from an 
early age (1-year after birth in humans), in a highly regulated process known as age-
related thymic involution (Boehm and Swann, 2013; Chaudhry et al., 2016). 
Involution is defined by several hallmarks: decrease of thymus size, reduction of T 
cell production, loss of cortico-medullary architecture and the invasion and 
replacement of the tissue by adipose cells (reviewed in Chinn et al., 2012). It 
contributes to the immuno-senescence phenomenon where elderly people become 
more prone to novel infections and cancer, due to poorer immuno-surveillance 
(Palmer, 2013). In circumstances where a new T cell repertoire is required, such as 
following bone marrow transplantation, the lack of significant thymic capacity poses 
a more acute challenge (Chaudhry et al., 2016). Therefore, interventions to 
regenerate the thymus are of considerable clinical value.  
Thymus regeneration strategies belong to two broad categories: (1) tissue 
regeneration rooted in chemical stimulation of residual TEC progenitors, and (2) 
tissue replacement. Fibroblast Growth Factor 7 (FGF7), Interleukin 22 (IL22) and 
enforced Forkhead Box Protein N1 (FOXN1) expression have all been shown to 
promote thymus regeneration (Alpdogan et al., 2006; Bredenkamp et al., 2014a; 
Dudakov et al., 2012). Alternatively, TECs can be generated from directed 
differentiation of pluripotent stem cells or trans-differentiation from unrelated tissues 
(Bredenkamp et al., 2014b; Parent et al., 2013; Sun et al., 2013), underlying the 
potential of tissue replacement. Importantly, in order to constitute a viable therapy, 
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such tissue needs to contain long-term self renewing TEC progenitors, and both 
cTEC and mTEC compartments (reviewed in Bredenkamp et al., 2015). In this 
regard, our understanding of thymus development, the way embryos build the 
thymus for the first time, will provide valuable insights for attempts to regenerate the 
thymus, during which the need to rebuild the organ arises.  
 
1.2 T cell development 
Haematopoietic progenitors enter the adult thymus at the CMJ. The earliest 
intrathymic progenitors can differentiate into T cells, B cells and myeloid cells (Luc 
et al., 2012). The initial seeding of the thymic primordium by progenitors is 
dependent on FOXN1 and its direct targets, Chemokine (C-C motif) Ligand 25 
(CCL25), C-X-C Motif Chemokine 12 (CXCL12) and Kit ligand (Calderon and 
Boehm, 2012; Luis et al., 2016). In the thymus, thymocytes go through sequential 
stages of differentiation characterized by cell surface marker expression. Those 
stages are CD4- CD8- (double negative, DN), CD4+ CD8+ (double positive, DP), and 
finally CD4+ CD8- or CD4- CD8+ (single positive, SP). The DN stages can be further 
divided by the expression of CD44 and CD25 into DN1 (CD44+ CD25-), DN2 
(CD44+ CD25+), DN3 (CD44- CD25+) and DN4 (CD44- CD25-) stages (reviewed in 
Shah and Zuniga-Pflucker, 2014). The importance of cTECs, mTECs and cortico-
medullary architecture for the differentiation and selection of developing T cells is 
discussed here (Summarized in Figure 1.1A,B). 
The specification of T cells is regulated by Notch signalling. Activated by ligand 
Delta-like 4 (DLL4) on cTECs, early thymic progenitors (ETPs) upregulate Hes1, 
Gata3, Tcf7 and Bcl11b, and these factors steer ETPs into the T cell lineage (Shah 
and Zuniga-Pflucker, 2014). Once the Notch signal is received, DN2 thymocytes in 
the cortex begin rearranging the V(D)J region of the T Cell Receptor β (Tcrb) locus 
by RAG1 and RAG2 recombinases, and by the DN3 stage assemble the pre-TCR 
complex with invariant pre-TCRα and CD3. DN2 thymocytes can also rearrange 
TCRγδ chain and become γδ-T cells (Krangel, 2009). Successful TCRβ 
rearrangement triggers ligand-independent pre-TCR signalling, resulting in extensive 
proliferation at the subcapsular cortical region, followed by rearrangement of TCRα 
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locus and the upregulation of CD4 and CD8 (Yamasaki and Saito, 2007). These DP 
cells migrate through deep cortex to undergo positive selection by engaging self 
peptide-MHC complexes displayed on cTECs.  
Affinity between TCR and MHC is crucial for the outcome of positive selection, 
since only weak engagement promotes cell survival, while the lack of physical 
binding leads to death by neglect, and strong affinity to apoptosis, respectively 
(reviewed in Klein et al., 2014). DP thymocytes further differentiate into CD4 or 
CD8 SP T cells in the cortex as they become restricted to either MHCII or MHCI. 
cTECs orchestrate these processes too with β5t (a component of thymoproteasome) 
and Cathepsin L (CtsL) (Takada et al., 2017). Thymoproteasome is important for the 
generation of high affinity MHCI ligands, and consequently the number of CD8+ SP 
T cells was considerably hampered in β5t deficient mice (Murata et al., 2007). 
Moreover, Cathepsin L catalyzes the processing of MHCII in endosome as well as 
the production of self peptide to be loaded on MHCII in lysosome. In the absence of 
these combined actions, CD4 SP T cells in CtsL mutants were severely impaired 
(Honey et al., 2002; Nakagawa et al., 1998). 
Thymocytes passing the positive selection checkpoint then migrate from cortex to 
medulla. This migration occurs in a chemokine receptor CCR7-dependent manner 
(Ueno et al., 2004). Although negative selection against ubiquitously expressed self 
antigens also proceeds in the cortex (Krueger et al., 2017), the selection against 
tissue restricted antigens (TRAs), proteins expressed in specific peripheral tissues, 
only occurs in the medulla (Klein et al., 2014). The vast antigen diversity is the 
results of promiscuous gene expression mediated by Autoimmune Regulator (AIRE) 
and FezF2 in mTECs (Anderson and Su, 2016; Takaba et al., 2015). TRAs can be 
directly presented on mTECs, or on DCs via transfer from mTECs. Interestingly each 
TRA is only expressed in 1-3% of mTECs, and it takes 200-500 mTECs to represent 
the full TRA repertoire (Klein et al., 2014). It has been estimated that SP T cells 
encounter hundreds of antigen presenting cells before exiting the thymus, thus 
minimizing the risk of autoreactivity (Klein et al., 2014).  
Peripheral T cells that escape negative selection are controlled by regulatory T cells 
(Tregs), and the initial development of CD4+ CD25+ Foxp3+ regulatory T cells also 
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occurs in the thymic medulla (reviewed in Lio and Hsieh, 2011). CD4 SP T cells 
differentiate via either of two progenitor states, CD25+ Foxp3- or CD25- Foxp3+, 
before acquiring the fully mature phenotype (Lio and Hsieh, 2008; Tai et al., 2013). 
Functional mTECs are instrumental to Tregs generation in the thymus, since mTEC 
deficient Relb-/- thymus grafts contain dramatically reduced precursor and mature 
Tregs (Cowan et al., 2013). Striking similarities exist between Treg generation and 
negative selection, although autoreactive TCRs on Tregs are of lower affinity (Klein 
et al., 2014). A recent study found that both precursor and mature Tregs in thymus, 
defined by CD25 and Foxp3, consist of both de novo and recirculating Tregs from 


















Figure 1.1 T cell development is coupled to the orderly migration of 
thymocytes in the thymus.  
(A) The stereotypical route of thymocyte migration in the thymic stroma. CEC 
– cTEC, MEC – mTEC, B – thymic B cell, NK – natural killer cell, DC – 
dendritic cells. (Blackburn and Manley, 2004)  
(B) cTECs and mTECs orchestrate progression to increasingly mature 












1.3 Overview of thymus development 
The thymus anlage forms from the third pharyngeal pouches (3PPs), a pair of 
evaginations of the pharynx, which exist from E9.5 to E11.5 in the mouse embryos. 
The 3PPs are the common primordia for the thymus and the parathyroid, which are 
clearly demarcated by the expression of ventral Foxn1 and dorsal Glial Cells Missing 
2 (Gcm2) respectively by E11.25 (Gordon et al., 2001). The common primordia 
separate from the pharynx at E11.5, and the thymus and parathyroid separate from 
each other at E12.5. The two thymus lobes then migrate caudally from the neck 
region and join above the heart, where further growth and differentiation will 
proceed (reviewed in Gordon and Manley, 2011). Of note, both the thymic primordia 
and TECs dramatically change their morphology in early organogenesis. First, from 
E10.5 to E11.5 the two dimensional (2D) endodermal layer thickens, transforming 
from a simple to a more stratified epithelium. In the following two days the 3PP 
lumen collapses, TECs lose apico-basal polarity and form an extensive meshwork 
underpinning a fully three-dimensional (3D) rudiment (Itoi et al., 2001).  
The origin of TECs, thymocytes and other thymic cell types was first probed using 
the chick-quail chimera system. Quail pharyngeal endoderm transplanted into chick 
hosts gave rise to TECs in the chimeric thymus, whereas T cells and thymic 
mesenchyme were of host origin (Le Douarin and Jotereau, 1975). This indicates that 
TECs originate from the endoderm. Moreover, the potency of murine thymic cells 
can be studied by transplanting tissue or reaggregated thymic organ culture (RTOC) 
under the kidney capsule (Blackburn and Manley, 2004; Sheridan et al., 2009). 
Dissected E9.0 3PP endoderm, when grafted, grew into an ectopic thymus composed 
of normal cortico-medullary architecture and capable of supporting T cell 
development, establishing the endoderm as the sole origin of TECs (Gordon et al., 
2004). Crucially this study suggested that the thymic fate is inherent to a subset of 
cells in the 3PP endoderm, even though definitive markers such as Foxn1 are not yet 
switched on.  
Two laboratories independently identified Placenta-expressed Transcript 1 (PLET1), 
the antigen targeted by MTS20 and MTS24 monoclonal antibodies (Depreter et al., 
2008), as a marker for a fetal TEC population that can reconstitute the thymus in 
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RTOC grafts (Bennett et al., 2002; Gill et al., 2002). Improved flow cytometry 
techniques led to the finding that nearly all TECs express PLET1 at E12.5, and the 
proportion of PLET1+ TECs declines subsequently in organogenesis (Nowell et al., 
2011). The differentiation of TECs has also been characterized with cytokeratin 
expression. In the early thymus rudiment most TECs are cytokeratin K5+ K8+, and 
later downregulate either marker to become K5+ K8- mTECs or K5- K8+ cTECs 
(Bennett et al., 2002; Gill et al., 2002; Klug et al., 2002). Of interest, K5+ K8+ TECs 
are also found in the CMJ and were thought to be a likely source of TEC progenitors 
in adult thymus (Klug et al., 1998). 
The maturation of TECs is dependent on signals from mesenchymal cells and 
developing T cells (Auerbach, 1960; van Ewijk et al., 1994). Neural crest-derived 
mesenchyme coalesces around the thymic lobes to form the capsule, and these cells 
secrete FGF factors to stimulate the proliferation of immature TECs (Jenkinson et al., 
2003; Revest et al., 2001). Colonization of the thymus by haematopoietic cells begins 
at E11.5 (Luis et al., 2016), coinciding with the onset of Foxn1 expression and the 
shift of epithelial morphology. In the hCD3ε transgenic mice where thymopoiesis 
was blocked at DN1 stage, TECs were found to be in a 2D configuration and 
predominantly K5+ K8+, and large cysts were present in the hypoplastic thymi (Klug 
et al., 1998; Van Ewijk et al., 2000). This likely represents failure to maintain 
organization as haematopoietic progenitors are not required for the initial patterning 
of fetal epithelium (Klug et al., 2002). In contrast, in Rag1-/- mutants where T cell 
development was blocked at the DN3 stage, cTEC organization was reticular and 
differentiated K5- K8+ cTECs were found, although mTECs were barely detectable 
(Klug et al., 1998). Indeed, the elaboration of the mTEC sub-lineage occurs in the 
presence of more mature, positively selected T cells (Hikosaka et al., 2008). Taken 
together these results show that TEC differentiation past the initial establishment 







1.4 Molecular regulation of thymus organogenesis 
1.4.1 FOXN1 
The investigation of FOXN1 began with the description of the ‘nude’ mutant 
phenotype (Flanagan, 1966), in which thymus development is arrested very early in 
organogenesis and thymopoiesis does not occur (Cordier and Haumont, 1980; 
Pantelouris, 1968; Pantelouris and Hair, 1970). Positional cloning and targeted gene 
disruption confirmed Foxn1, which encodes a DNA-binding protein, as the nude 
gene and the mutation is a single nucleotide deletion in Foxn1 exon 3 (Nehls et al., 
1996; Nehls et al., 1994). Elegant cross-transplantation studies of thymus and bone 
marrow between nude and wildtype mice showed that the thymic phenotype in nude 
mice was due to stromal rather than haematopoietic defects (Wortis et al., 1971). 
Furthermore, chimera analysis showed that nude TECs could be incorporated into a 
wildtype thymic epithelium, but they retain immature markers, suggesting that 
FOXN1 acts cell-autonomously to promote TEC differentiation (Blackburn et al., 
1996). Indeed, the potency of Foxn1 knockout TECs resembles that of 
undifferentiated bipotent TEC progenitors, since quasi-clonal postnatal activation of 
Foxn1 in these cells was sufficient to resume the formation of a patterned and 
functional thymus (Bleul et al., 2006).  
The targets of FOXN1 in TECs can be broadly divided into genes that are 
responsible for thymocyte development in the thymus, and those that act cell 
autonomously to regulate TEC differentiation. Several studies have shown that 
FOXN1 directly activates genes essential for nurturing T cell migration, selection 
and maturation, including Dll4, Ccl25, Cxcl12, Psmb11 and Cd83 (Bajoghli et al., 
2009; Uddin et al., 2017; Zuklys et al., 2016). Of these targets, DLL4 activates Notch 
receptors on haematopoietic progenitors, committing them to the T cell lineage while 
suppressing the alternative B cell fate (Koch et al., 2008). CCL25 and CXCL12 are 
chemokines that direct the cell migration within the thymus (Hu et al., 2015). 
Psmb11 encodes the β5t unit of thymoproteasome and is required for MHCI function 
and selection of CD8 SP T cells (Murata et al., 2007). Knockout of cell surface 
protein CD83 is known to stabilize surface MHCII and boost the positive selection of 
CD4+ SP T cell (Fujimoto et al., 2002).  Forced expression of some of these targets 
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in Foxn1-/- TECs rescued certain aspects of T cell development, while TECs remain 
undifferentiated (Calderon and Boehm, 2012). This showed that the two distinct roles 
of FOXN1 can be uncoupled. Abnormal endothelial and mesenchymal cells 
phenotypes have also been observed in Foxn1 mutant thymi (Bryson et al., 2013; 
Mori et al., 2010), indicating that FOXN1 regulates other components of the stroma. 
Foxn1 gene expression in TECs is initiated at E11.25, when the thymic identity of 
the domain is already determined (Gordon et al., 2001; Gordon et al., 2004). Using 
hypomorphic Foxn1 strains, it has been demonstrated that TEC differentiation occurs 
in a progressive manner, with each step forward requiring higher levels of FOXN1 
(Nowell et al., 2011; Su et al., 2003). The specification of the mTEC lineage, 
however, takes place even in TECs expressing little or no Foxn1, suggesting that 
TEC lineage divergence precedes, or is independent of, Foxn1 expression (Baik et 
al., 2016; Nowell et al., 2011). In terms of regulatory mechanisms, FOXN1 appears 
to exert a mitogenic effect on TEC progenitors (Itoi et al., 2001), and this is indeed 
consistent with the observations in postnatal thymus (Bredenkamp et al., 2014a; 
Chen et al., 2009). Furthermore, though not definitively proved, several transcription 
factors associated with FOXN1, such as P63 and PAX1 (Nowell et al., 2011; Zuklys 
et al., 2016), are candidates that may account for the differentiation block in Foxn1 
mutants. What is more, TEC differentiation also requires crosstalk with thymocytes 
(van Ewijk et al., 1994). Through facilitating T cell development, FOXN1 is 
indirectly involved in regulating TEC maturation by ensuring that thymic crosstalk 
occurs normally.  
 
1.4.2 Transcription factor network  
A genetic regulatory network (GRN) of transcription factors defines thymic identity 
prior to, and eventually leads to, the initiation of Foxn1 expression (Figure 1.2). It 
was postulated that, based on a number of single or compound knockout mice, this 
GRN consists of Hoxa3, Pax1, Pax9, Eya1, Six1 and Tbx1 (Blackburn and Manley, 
2004; Hollander et al., 2006). More recent data have largely confirmed this theory, 
although the specific role of Tbx1 has been revised (Reeh et al., 2014). Moreover, 
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gene expression analysis has suggested additional components in this GRN, notably 
Foxg1 and Islet1 (Wei and Condie, 2011).  
In the foregut/pharyngeal region, Homeobox A3 (Hoxa3) is expressed in both the 
endoderm and the surrounding mesenchyme (Manley and Capecchi, 1995). Deletion 
of Hoxa3 resulted in the lack of thymus, parathyroid and a greatly reduced thyroid 
gland in newborns, which can be traced to the malformation of E10.5 3PP/4PP 
(Chisaka and Capecchi, 1991; Manley and Capecchi, 1995). In Hoxa3-/- mice, Foxn1 
expression is delayed but nevertheless initiated, thus Hoxa3 alone does not define 
thymic identity (Chojnowski et al., 2014). A rise in apoptosis was observed in 
Hoxa3-/- 3PP prior to Foxn1 activation, suggesting that the lack of thymus in mutant 
neonates is due to enhanced cell death (Chojnowski et al., 2014). Conditional 
deletion of Hoxa3 in the endoderm led to a more severe thymic phenotype than 
deletion in mesenchyme, and this may be explained by the fact that Bmp4 expression 
is dependent on Hoxa3 only in the endoderm (Chojnowski et al., 2014).  
Paired Box 1 (PAX1) and Paired Box 9 (PAX9) are related transcription factors that 
share high degrees of homology (reviewed in Blake and Ziman, 2014). Both genes 
are expressed in the E10.5 3PP (Peters et al., 1998; Wallin et al., 1996), however 
their knockout phenotypes are considerably different. The Pax9-/- mice display a 
3PP/4PP growth defect at E11.5 (Peters et al., 1998) and instead of undergoing 
normal migration, a highly hypoplastic mass of thymic tissue remains in the neck 
region (Hetzer-Egger et al., 2002). These ectopic pharyngeal polyps express Foxn1, 
support initial thymocyte colonization, but diminish after E16.5 due to pervasive 
apoptosis (Hetzer-Egger et al., 2002). In contrast, thymic rudiments migrate normally 
in Pax1 mutants, albeit exhibiting mild growth retardation, large cysts and delay in 
DN-to-DP thymocyte transition (Wallin et al., 1996).  
Of note, the maintenance of Pax1 expression following initiation is Hoxa3-dependent 
(Manley and Capecchi, 1995), yet Hoxa3 expression is unaffected in Pax1 Pax9 
double knockouts (Zou et al., 2006), suggesting that Hoxa3 is upstream of Pax1. 
What is more, losing one Hoxa3 allele exacerbated the Pax1 mutant phenotype (Su et 
al., 2001; Su and Manley, 2000). The compound phenotype of Hoxa3+/- Pax1-/- 
thymus consists of more severe aberrations detected in Pax1 mutants – hypoplasia, 
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cysts and DP arrest, and additional defects – stalled migration, low epithelial MHCII 
expression and low DN count. These data indicate that HOXA3 regulates thymus 
organogenesis through both PAX1 and other independent mechanisms. 
Eyes Absent Homolog (EYA) and Sine Oculis Homeobox Homolog (SIX) factors 
form transcriptional complexes in a highly conserved fashion. Eya1 and Six1 are 
expressed in the pharyngeal pouch and subsequently in fetal thymus (Xu et al., 2002; 
Zou et al., 2006). The thymus-parathyroid primordium is not formed in Eya1-/- mice 
(Xu et al., 2002), whereas in Six1-/- or Six1-/- Six4-/- double knockout the 3PP 
rudiment forms but rapidly degenerates due to apoptosis (Zou et al., 2006). Notably, 
Six1 expression is reduced in Eya1-/- primordia, and Eya1-/- Six1-/- double mutants 
exhibit additional aberrations compared to either single knockout, such as lower 
expression of Pax1, Fgf8 and Wnt5b (Xu et al., 2002; Zou et al., 2006). Since EYA1 
lacks DNA-binding capacity (Rebay et al., 2005), taken together these data reflect 
that there may be redundancy between SIX1 and SIX4 regarding EYA1 binding, and 
that EYA1 may act through alternative mechanisms, possibly via its phosphatase 
activity. 
Deletion of chromosome region 22q11.2 causes DiGeorge syndrome (DGS), in 
which patients present a diverse range of symptoms including immune compromise 
as a result of thymus hypoplasia or aplasia (reviewed in Hollander et al., 2006). 
Knockout of the T-box 1 (Tbx1) gene in mice recapitulated the DGS phenotype, 
confirming that its deletion is largely responsible for the abnormalities (Jerome and 
Papaioannou, 2001; Lindsay et al., 2001). Tbx1 is expressed in the pharyngeal pouch 
endoderm and arch mesenchyme in the pharyngeal region (Lindsay et al., 2001), 
however endoderm specific knockout of Tbx1 is sufficient for the loss of posterior 
pharyngeal pouches and their derivatives (Arnold et al., 2006). Interestingly, Tbx1 
gain-of-function also led to thymus hypoplasia (Vitelli et al., 2009), underlining the 
importance of dynamic Tbx1 expression in thymus organogenesis. Constitutively 
active Tbx1 triggered by Foxn1Cre demonstrated that TBX1 specifically represses 
Foxn1, and that Tbx1 downregulation is necessary for TEC differentiation (Reeh et 
al., 2014). Using live imaging, a recent study showed that pharyngeal pouch 
formation, the pre-requisite for thymus development, fails in mutant tbx1 zebrafish 
(Choe and Crump, 2014). In conclusion, Tbx1 plays a temporary role to regulate 
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pharyngeal pouch patterning and morphogenesis, partly by activating Fgf8 and Pax9 
(Arnold et al., 2006; Okubo et al., 2011). It is then repressed to permit TEC 
differentiation.  
It is evident that components of this proposed GRN of thymic anlage cross-interact 
extensively. This may explain the fact that despite severe abnormalities in the 
mutants of Pax1, Pax9, Hoxa3 and Six1, a thymic anlage initially formed 
nonetheless. Indeed, this relative stability is a hallmark of gene networks (Payne and 
Wagner, 2015). Contrary to the nude phenotype, in which thymic rudiments survive 
well into adulthood, the thymic primordia in most of these knockouts degenerate 
through apoptosis, with the exception of Pax1. This indicates that TEC 
differentiation can be divided into two phases, the pre-FOXN1 and the post-FOXN1 
(Nehls et al., 1996). In the pre-FOXN1 phase, the GRN ensures that specified TEC 
progenitors reach a stable state in which they are poised for differentiation and robust 
from apoptosis. Once FOXN1 is activated, it mediates the differentiation of both 
mTEC and cTEC sub-lineages, as well as substantial proliferation.  
 
1.4.3 Hedgehog (Hh) 
Sonic Hedgehog (Shh) and its receptor Patched1 (Ptc1) are expressed in E10.5 3PP 
(Moore-Scott and Manley, 2005). In the Shh-/- null mutants, reduced pouch size was 
detected as a result of cell death, and whilst the parathyroid marker Gcm2 was lost, 
the thymic domain in 3PP marked by Bmp4 and later Foxn1 appeared expanded 
(Moore-Scott and Manley, 2005). Constitutively active Hh signalling in pharyngeal 
endoderm did not convert epithelial cells into GCM2+ parathyroid fate. Rather, it 
induced TBX1 which in turn repressed Foxn1 expression (Bain et al., 2016; Reeh et 
al., 2014). Therefore, Hh activity patterns the primordium by regulating the 
competence of cells to become thymic or parathyroid.  
Hh signalling continues to be active in the developing thymus following the initial 
patterning. Smaller thymi are present in Shh-/- nulls until development fails around 
E16.5 (Shah et al., 2004). Fetal culture of Shh-/- thymi, or blocking Hh signalling 
with antagonist Hhip, revealed that Hh-deficient FTOC exhibit decreased numbers of 
cTECs and mTECs, with the latter more severely affected (Saldana et al., 2016). 
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What is more, ablation of the pathway, genetically or chemically, led to increased 
levels of MHCII accompanied by a reduced frequency of AIRE+ mTECs (Saldana et 
al., 2016). This evidence points to a role of Hh in regulating TEC differentiation, 
although it is uncertain whether the effects are entirely cell autonomous, or partly 
indirect through thymic crosstalk, since SHH is also a potent regulator of thymocyte 
development (Barbarulo et al., 2016).  
 
1.4.4 WNT 
Wnt ligands WNT1, WNT4 and WNT5b are expressed in the thymic anlage as early 
as E10.5, with WNT4 persisting robustly into adulthood (Balciunaite et al., 2002). 
Using cell lines derived from primary cTECs, it was shown that both Wnt activation 
by lithium chloride and co-culture with WNT4-transfected thymocytes led to 
elevated Foxn1 expression (Balciunaite et al., 2002). These data support the 
hypothesis that Wnt pathway may initiate Foxn1 and consequently TEC 
differentiation. A later study provided further evidence by co-culturing E15.5 thymi 
with supernatant from a WNT4-secreting cell line (Kvell et al., 2014); TECs isolated 
after culture exhibited elevated expression of Foxn1.  
Moreover, Heinonen and colleagues analyzed the fetal thymi of Wnt4-/- knockout 
mice. TEC cellularity in WNT4 deficient mice is reduced by half compared to 
wildtypes, and mTEC frequency in the epithelium appears lower. Interestingly, 
conditional deletion of Wnt4 at neonatal stages produced a stronger phenotype (lower 
TEC count and mTEC frequency) than deletion in adult mice, suggesting that the 
WNT4 effect on TECs is temporally restricted (Heinonen et al., 2011). In addition, 
TEC specific knockout of Gpr144, required for WNT ligand transport to the cell 
surface, exhibited reduced thymocyte cellularity apparent by birth (Brunk et al., 
2015). T cell development was not blocked, however a significant decrease in TEC 
number and increased TEC apoptosis rate were observed (Brunk et al., 2015). Thus, 
the pathway may function in an autocrine fashion, where WNT ligand secreted by 
TECs activates WNT signalling in TECs to enhance cellular survival. 
On the other hand, elevated Wnt activity can also have a profound impact on the 
thymic epithelium. Loss of the Wnt antagonist Kremen1 enhanced Wnt activity, and 
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as a result the cortico-medullary architecture was gradually lost in fetal and postnatal 
thymus (Osada et al., 2006). An even more dramatic collapse was observed in two 
independent studies where the canonical Wnt effector β-catenin was stabilized 
specifically in TECs (Swann et al., 2017; Zuklys et al., 2009). Typical reticular 
thymic epithelial structure was disrupted in the fetal thymus, and Foxn1 expression 
was either lost or reduced. The remaining epithelium appeared small, cystic and 
unable to be colonized by haematopoietic cells. In comparison, overexpression of 
WNT4 alone produced milder defects in primordium migration and TEC 
differentiation (Swann et al., 2017). Of note, various Wnt antagonists were activated 
in the gain-of-function model, indicating an intrinsic negative feedback loop in fetal 
TECs (Zuklys et al., 2009).  
In the context of thymic homeostasis, the induction of Wnt antagonist Dickkopf 
Homolog 1 (DKK1) resulted in a significant but reversible fall in thymus size and 
cellularity (Osada et al., 2010). The inducible DKK model also showed decrease in 
Foxn1 expression and perturbed epithelial architecture, reminiscent of age-related 
involution (Osada et al., 2010). The expression of many Wnt genes in TECs declines 
with age, but can be restored by the overexpression of Foxn1 to the levels of young 
TECs (Bredenkamp et al., 2014a).  
In conclusion, Wnt ligands, especially WNT4, may have a role in activating Foxn1 
expression in thymus organogenesis. The appropriate range of Wnt activity is crucial 
to safeguard the differentiation and architecture of the thymic epithelium.  
 
1.4.5 Bone Morphogenetic Proteins (BMP) 
The morphogens BMP2, BMP4, BMP7 and their antagonists Chordin, Noggin and 
Twisted Gastrulation (Tsg) are all expressed during thymus organogenesis, either by 
endodermal progenitors/TECs or by neural crest derived mesenchyme (Bleul and 
Boehm, 2005; Graf et al., 2002; Patel et al., 2006; Scott et al., 2000). Expression of 
NOGGIN driven by the Foxn1 promoter led to stalled migration of the thymus, as 
well as a significant reduction in thymus size (Bleul and Boehm, 2005). Sustained 
exposure to NOGGIN also triggered part of the epithelium to lose Foxn1 expression 
and revert to cystic structure indicative of immature precursor cells (Soza-Ried et al., 
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2008). Specific deletion of Bmp4 using Foxg1Cre, which is active as early as E9.5 in 
the 3PP endoderm and surrounding mesenchyme, resulted in morphogenetic 
aberrations and smaller thymi, a phenotype not dissimilar to that observed of 
misexpression of Noggin (Gordon et al., 2010). Moreover, deletion of Bmp4 with 
Wnt1Cre and Foxn1Cre, which specifically target neural crest derived mesenchyme 
and committed TECs respectively, showed that while the requirement for BMP4 for 
thymus size continues after Foxn1 is switched on, migration of the rudiments only 
requires an early pulse of BMP4, possibly to ensure that the mesenchymal cells 
mature normally and form organized thymic capsule (Gordon et al., 2010).  
The relationship between BMP signalling and Foxn1 expression in development is 
complex. The addition of BMP4 in FTOC medium increased the expression of Foxn1 
in TECs (Tsai et al., 2003). In our hands, the combination of BMP4 and FGF8, but 
not BMP4 alone, led to Foxn1 upregulation in E10.5 3PP culture (Popis, 
unpublished). However, neither forced Noggin expression nor Foxg1Cre induced 
Bmp4 deletion completely abolished Foxn1, although in the former case part of the 
thymic rudiment indeed lost Foxn1 and exhibited a cystic structure (Bleul and 
Boehm, 2005; Gordon et al., 2010; Soza-Ried et al., 2008). Remarkably, when BMP 
signalling is suppressed by NOGGIN, Bmp2 and Bmp4 are activated in a negative 
feedback fashion (Bleul and Boehm, 2005). This, and redundancy shared by other 
BMP factors, may account for the relatively normal Foxn1 expression in the 
Foxg1Cre Bmp4 deletion model. In addition, foxn1 downregulation was observed in 
the zebrafish larval thymus subsequent to Noggin misexpression or BMP inhibitor 
treatment (Soza-Ried et al., 2008). Foxn1 initiation in avian thymic rudiments can 
also be abolished by Noggin, though this effect is lost later in development (Neves et 
al., 2012). Taken together, these studies revealed an evolutionarily conserved role of 
BMP signalling in positively regulating Foxn1 expression, but this effect is likely to 
depend on the maturation status of TECs, as well as the overall signalling 
environment TECs encounter. 
Some aspects of the BMP loss-of-function models resemble those of WNT gain-of-
function, such as incomplete thymic rudiment migration, reduced cellularity and 
Foxn1 suppression (Bleul and Boehm, 2005; Gordon et al., 2010; Soza-Ried et al., 
2008; Swann et al., 2017; Zuklys et al., 2009). By simultaneously overexpressing 
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Wnt4 and Noggin, Swann and colleagues observed a more severe phenotype – 
smaller rudiment size and poor migration – than Noggin alone (Swann et al., 2017). 
Therefore, the proliferation and maturation of early TECs likely require a BMPhigh 
WNTlow/med environment. What is more, a number of studies concluded that BMP 
ligand treatment results in the arrested development of thymocytes (Graf et al., 2002; 
Hager-Theodorides et al., 2002; Tsai et al., 2003). Since BMP ligands are soluble 
morphogens, this highlights the importance of intricate BMP pathway regulation in 
thymic organogenesis, namely the initial high activity to establish TEC program and 
morphogenesis, and a following phase of modest expression compatible with T cell 
progression.  
 
1.4.6 Fibroblast Growth Factors (FGF) 
The expression of FGF ligand Fgf8 can be detected in the pharyngeal pouch 
endoderm and surface ectoderm when these structures first appear at E9.5 (Crossley 
and Martin, 1995). Embryos carrying hypomorphic alleles of Fgf8 exhibit a variety 
of thymus phenotypes linked to the rise in cell death in pharyngeal arches, ranging 
from hypoplasia to the complete absence of the thymus (Abu-Issa et al., 2002; Frank 
et al., 2002; Macatee et al., 2003). Fgf8 is a TBX1 target and is downregulated in the 
Eya1 knockout (Arnold et al., 2006; Zou et al., 2006), hence it may be an important 
effector of the early thymic GRN program. In this context, the requirement of FGF8 
differs amongst the cells in the primordium. In contrast to promoting expansion of 
the thymic domain, sustained high FGF activity decreased parathyroid size and 
prevented pouch separation from the pharynx (Gardiner et al., 2012). Remarkably, 
modulation of FGF8 activity by FGF antagonists Sprouty1 and 2 also conditions the 
thymic capsule and mesenchymal cells to secrete FGF10 and thereby indirectly 
regulates the proliferation of fetal TECs (Frank et al., 2002; Gardiner et al., 2012).  
Alternative splicing of the FGF Receptor 2 (Fgfr2) gene produces two isoforms, 
FGFR2IIIb and FGFR2IIIc. FGFR2IIIb serves as receptor for two FGF ligands, 
FGF7 and FGF10, in the developing thymus (Ohuchi et al., 2000; Revest et al., 
2001). In E12-14 thymus, these FGF ligands are most prominently expressed in the 
capsule, which originates from earlier mesenchyme, while FGFR2IIIb expression is 
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restricted to the epithelium (Revest et al., 2001). Deficient FGF10, FGFR2IIIb, or 
blocking with soluble dominant negative FGF receptors produced the fetal thymic 
hypoplasia phenotype (Celli et al., 1998; Ohuchi et al., 2000; Revest et al., 2001). 
Combined with the facts that mitotic TECs are less abundant in the absence of 
FGF10 or FGFR2IIIb, and that the addition of FGF7 or FGF10 rescued proliferation 
in mesenchyme-deprived reaggregate cultures (Jenkinson et al., 2003; Revest et al., 
2001), it appears that the FGF ligands act as mitogenic stimulants in mesenchymal-
epithelial crosstalk. In addition, Fgf7 is upregulated as thymocytes mature (Erickson 
et al., 2002), indicating that T cells could be an alternative source of FGF7 later in 
development.  
In summary, FGF signalling occurs in two waves in thymus development. First, 
FGF8 promotes the survival of 3PP cells and, through negative feedback, governs the 
patterning and morphogenesis of the rudiments. This is followed by mesenchymal-
epithelial interaction involving FGF7 and FGF10 to enhance TEC proliferation.  
 
1.4.7 Tumour necrosis factor superfamily (TNFSF)  
Several TNFSF factors have been shown to play synergistic roles in mTEC 
development through the canonical and non-canonical NFκB pathway (reviewed in 
Nitta et al., 2011). Briefly, the canonical pathway is dependent on the degradation of 
Inhibitor of κB (IκB), and the non-canonical pathway signals through NFκB inducing 
kinase (NiK) (reviewed in Dejardin, 2006). Mice with deletions in the NFκB 
components RelB (Burkly et al., 1995), NiK (Kajiura et al., 2004), lymphotoxin β 
receptor (LTβR) (Boehm et al., 2003), TRAF6 (Akiyama et al., 2005) and RANK 
receptor (Akiyama et al., 2008) develop autoimmunity, suggesting a prominent role 
of NFκB in regulating mTECs and central tolerance. Notably, T cell developmental 
arrest caused a similar mTEC phenotype, and this mutual dependence between 
thymocytes and the stroma was termed thymic crosstalk (van Ewijk et al., 1994). 
LTβR signalling is specifically required for a subset of AIRE- CCL21+ mTECs 
(Lkhagvasuren et al., 2013). LTβR-/- mice show disorganized, hypoplastic medulla 
and presented autoimmunity in multiple organs despite detectable levels of Aire and 
promiscuous gene expression (Boehm et al., 2003). This apparent contradiction may 
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result from AIRE-independent TRA expression mediated by FezF2, a proposed 
target gene of LTβR (Takaba et al., 2015). However, this conclusion has also been 
challenged, as another study found FezF2 expression in LTβR deficient TECs 
(Cosway et al., 2017). Instead, the autoimmune phenotype in LTβR-/- mice seems to 
originate from impaired medullary dendritic cell function in negative selection, 
which is regulated separately from mTECs (Cosway et al., 2017).  
RANK ligand (RANKL, also known as TNFSF11) is a major facilitator of thymic 
crosstalk. Positively selected T cells secrete RANKL which promotes the 
proliferation of immature mTECs, the upregulation of maturation markers MHCII 
and CD80, and the activation of Aire (Hikosaka et al., 2008). Lymphoid tissue 
inducer cells (LTi, defined as CD4+ CD3-) also secrete RANKL (Rossi et al., 2007b), 
however this contribution seems minor since mice lacking LTi cells exhibit only a 
marginal proportional reduction in mTECs (Hikosaka et al., 2008). Given the vital 
importance of AIRE in negative selection, these results are fully consistent with the 
autoimmune phenotype of NFκB mutants. Two independent reporter lines showed 
that RANK receptor expression is negligible in E13.5 rudiments, which contain few 
mTECs, but increases afterwards as mTECs expand and mature (Akiyama et al., 
2016; Baik et al., 2016), in line with its role in instructing these processes. 
Furthermore, mTECs secrete osteoprotegerin (OPG) (Akiyama et al., 2014; Hikosaka 
et al., 2008), a soluble decoy receptor of RANKL that in effect functions as an 
antagonist of the pathway, thus preventing the hyper-stimulation of RANK.  
More recent investigations have established a framework of the mechanisms and 
temporal sequence of various TNFSF factors in mediating mTEC development. 
Agonist LTβR antibodies in FTOC raised the expression of Rank within 6 hours 
(Mouri et al., 2011), suggesting that LTβR is upstream to RANK in the cascade and 
conditions mTECs to respond to RANKL. A similar approach revealed that RANKL 
can activate CD40 in mTECs, making these cells receptive to CD40L secreted by 
thymocytes (Desanti et al., 2012). Double mutants of these three receptors again 
placed RANK at the epistatic centre, with LTβR/RANK and RANK/CD40 double 
knockouts exhibiting more severe mTEC hypoplasia than single knockouts alone 
(Akiyama et al., 2008; Mouri et al., 2011), but LTβR and CD40 showed no evidence 
of interaction (Mouri et al., 2011). It has also been shown that the ligands upregulate 
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largely distinct subsets of genes, and that only RANKL is responsible for activating 
AIRE (Bichele et al., 2016). Indeed, functional NFκB binding sites have been found 
in the regulatory region of Aire (Haljasorg et al., 2015).  
In terms of the intracellular pathway, RelB and TRAF6 mark two distinct 
checkpoints in the mTEC lineage. Relb deficient mTECs are arrested at a more 
primitive stage (RANKloMHCIIloCD24hi) than in Traf6 mutants (RANK+ MHCIImid), 
and the transition between the two progenitor states requires the combined 
stimulation of LTβR and RANK (Akiyama et al., 2016; Baik et al., 2016). Full 
maturation to MHCIIhi AIRE+ mTECs requires both TRAF6 and RANK stimulation 
(Akiyama et al., 2016). Crucially, Claudin (CLDN) 3,4hi SSEA1+ cells, the most 
primitive mTEC progenitors identified to date (Hamazaki et al., 2007; Sekai et al., 
2014), are present even in the more severe Relb mutant (Baik et al., 2016), hence 
mTEC specification occurs independently of thymic crosstalk.  
Along with TNFSF ligands, recent reports also shed light on novel regulators of 
mTEC development following the initial expansion of mTEC. An EGFR-STAT3 
axis appears to promote postnatal mTEC cellularity without affecting their 
maturation status (Satoh et al., 2016). The histone deacetylase HDAC3 is required 
for mTEC cellularity, maturation and the capacity to suppress autoimmunity, partly 
by repressing excessive Notch activity in postnatal mTECs (Goldfarb et al., 2016). In 
contrast, TGFβ ligand, through receptor TGFβR2, inhibits proliferation of postnatal 
mTECs (Hauri-Hohl et al., 2014). Together, these discoveries highlight that mTECs 











Figure 1.2 The time frame of TEC lineage progression, and the underlying 
regulatory mechanisms. Third pharyngeal pouch (3PP) endoderm identity is 
established in the presence of the gene regulatory network (GRN). Some 
genes (e.g. Pax1) continue to express in more differentiated TECs, while 
others (eg. Tbx1) are gradually downregulated. Polarized expression of 
signalling molecules (Shh and Bmp4) likely patterns 3PP into dorsal 
parathyroid and ventral thymic domains. The combined influence of the GRN 
and signalling pathways switches on Foxn1, the key regulator of TEC 
differentiation. Moreover, mesenchymal cells directly promote the 
proliferation of early fetal TECs by releasing mitogenic FGF7/10 ligands. If 
and how common TEPCs with cTEC and mTEC potential are maintained is 
unclear. How bipotent TEPCs are specified to become cTECs or mTECs also 
remains elusive. Having committed to the two lineages, the further maturation 
of mTECs into AIRE-expressing cells requires TNFSF/NFκB ligands, 







1.5 Potency of TEC progenitors (TEPCs) 
The bipotency of E12.5 EPCAM+ PLET1+ progenitors capable of giving rise to both 
mTECs and cTECs was demonstrated using a single cell transplantation assay (Rossi 
et al., 2006). The proportion of TECs expressing PLET1 reduces as thymus 
organogenesis advances, but a higher proportion of the emerging mTECs than cTECs 
are PLET1+ (Sheridan, unpublished), and remains so in adults (Ulyanchenko et al., 
2016). The murine Plet1 gene is of unknown function, poorly conserved (Depreter et 
al., 2008), and both PLET1+ and PLET1- E14.5/16.5 TECs show similar 
reconstitution activity (Rossi et al., 2007a). Thus, unlike the functional maturation 
marker MHCII, PLET1 represents a ‘neutral’ marker for TEC differentiation.  
Unipotent mTEC progenitors have been shown to contribute to the long-term 
maintenance of mTECs. Chimera analysis showed that the mTEC ‘islets’ (clusters of 
cells occupying single medullary regions) in fetal and young thymi are the products 
of clonal expansion from single progenitors (Rodewald et al., 2001). Unipotent 
mTEC progenitors can be isolated from E13.5 primordia using CLDN3/4 and SSEA1 
(Hamazaki et al., 2007; Sekai et al., 2014). These mTEC progenitors not only show 
long term reconstitution activity, but are able to correct autoimmunity in a mTEC-
deficient background (Sekai et al., 2014). Interestingly, CLDN3/4 were shown to 
localize specifically in the luminal side of E10.5 3PP (Hamazaki et al., 2007). 
Although this seems to suggest that apico-basal polarity may mark mTEC-biased 
progenitor, or directly regulate cell fate, the potency of CLDN3/4+ TECs prior to 
E13.5 has not been reported. Also, a clonal resolution lineage tracing has not been 
performed using CLDN3/4.  
In contrast, the separation of putative bipotent TEPCs from committed cTECs in 
developing thymi has proved more difficult, since early fetal TECs express high 
levels of mature cTEC markers such as β5t and CD205 (Baik et al., 2013; Ohigashi 
et al., 2015; Ohigashi et al., 2013). Indeed, the earliest TEPCs share a number of 
functions generally attributed to cTECs: instructing the homing of haematopoietic 
progenitors, providing Notch ligands, and supporting positive selection. Therefore a 
‘serial progression’ model has been proposed for the TEC lineage hierarchy: whereas 
cTEC represents a default fate for bipotent TEPCs since they share molecular and 
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functional similarities, specification of the mTEC lineage requires a currently 
unidentified signalling cue (reviewed in Alves et al., 2014).   
In adults, the MHCIIlo cTEC (cTEClo) population expressing α6 integrin and Sca-1 
was shown to contain TECs that contribute to mTEC and cTEC lineages when 
reaggregated with fetal thymus cells and grafted under the kidney capsule (Wong et 
al., 2014). Such bipotent reconstitution potential was also illustrated for Ly51+ 
PLET1+ TECs in adult thymus, and limiting dilution analysis estimated that 
approximately 1 in 90 cells in this minor population (<1% total TEC) accounted for 
this stem/progenitor cell behaviour (Ulyanchenko et al., 2016). Histological analysis 
revealed that individual Ly51+ PLET1+ TECs can differentiate into both mTECs and 
cTECs, and their progeny remained 9 months after reconstitution (Ulyanchenko et 
al., 2016). Although there are certain discrepancies between the two studies, such as 
the MHCII status, the stem/progenitor cells identified in each case nevertheless share 
the expression of cortical marker and a common localization (CMJ). What is more, 
the method adopted for these studies aimed to assay cellular potency, therefore the 
behaviour of these cells in homeostasis remains unclear.  
Regarding committed mTEC progenitors, the clonogenic activity of CLDN3/4+ 
SSEA1+ TECs is greatly reduced in the first month after birth, reflecting an altered 
self-renewing potential in this population (Sekai et al., 2014). As mTECs continue to 
turn over rapidly in adults (Gray et al., 2007), this raises the question as to how 
mTECs are maintained in homeostasis. The MHCIIlo mTEC subset possibly contains 
transit amplifying cells, since they could differentiate into post-mitotic, functionally 
mature MHCIIhi AIRE+ mTECs (Gray et al., 2007), but lack long term self-renewal 
capacity (Ulyanchenko et al., 2016; Wong et al., 2014). Interestingly, Podoplanin 
(PDPN) expressing cells residing at the CMJ gave rise to mTECs but not cTECs in 
lineage tracing, and may thus represent a source of steady state mTEC progenitors 
(Onder et al., 2015). As PDPN+ junctional TECs (jTECs) differentiate into mTECs, 
they typically downregulate PDPN and acquire mTEC markers (Onder et al., 2015). 
The common location of adult bipotent TEPCs and PDPN+ jTECs at the CMJ may be 
relevant to their role in maintaining thymic epithelium during homeostasis. Future 
interrogations of their progenitor-progeny relationship will shed light on this 
hypothesis.   
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Currently, how fetal TEC progenitors relate to their counterparts in the adult 
epithelium is not well understood. There are two broad hypotheses: either that adult 
TEPCs are set aside during development from ontogenetic TEPCs, or that they arise 
due to proximity to the niche environment (likely CMJ). All adult TECs are derived 
from β5t-expressing fetal progenitors, and such progenitors can contribute to both 
mTECs and cTECs until postnatal 1-week (Ohigashi et al., 2015; Ohigashi et al., 
2013). Moreover, while fetal and neonatal TECs cycle frequently, label-retaining 
cells have been identified in adult TECs (Dumont-Lagacé et al., 2014), although their 
cellular phenotype remains controversial. Based on the very scarce number of 
studies, we can infer that, in terms of cellular hierarchy, the thymic epithelium 
undergoes profound changes as expansion slows and cTEC/mTEC cell-fate boundary 
becomes less fluid in the first few postnatal weeks. Nonetheless, some rare CMJ-
localized TECs appear to either retain or acquire bipotency.  
Going forward, it is of interest to identify niche factors (signalling and scaffold 
molecules) that may play a part in maintaining adult TEPCs. More precise lineage 
tracing will also produce accurate information on how progenitor populations are 
related. In particular, since CLDN3/4+ SSEA1+ cells exhibit drastically lower self-
renewal activity in adults, it is probable that the progeny of these fetal mTEC 














Figure 1.3 A simplified view of the canonical Notch signalling pathway. 
Interaction between membrane-bound Notch ligands and receptors on 
adjacent cells triggers the cleavage of the Notch receptor, first to release the 
extracellular domain, then to liberate the intracellular domain. Notch 
intracellular domain (NICD) can then form a protein complex by binding 
RBPJκ and other co-factors in the nucleus. This complex is required to effect 











1.6 Notch signalling  
Cells in diverse invertebrate and vertebrate species communicate through a small 
number of signalling pathways in development. These pathways sense the physical 
and chemical environment the cells inhabit, often through ligand-receptor binding, 
and relay this information to the nucleus in order to facilitate transcriptional changes. 
Since each cell type or cell state has a distinct genetic and epigenetic make-up, the 
same pathway can be adopted multiple times and mediate unique responses in each 
cell type or at each developmental stage (reviewed in Gilbert, 2010). This list of 
pathways includes, but is not limited to, BMP/TGFβ, Hedgehog, Wnt, JAK/STAT, 
receptor tyrosine kinases, Hippo, and Notch. As discussed above, many of these 
pathways are relevant to thymus organogenesis (section 1.4).  
In the case of Notch, both ligands (Delta or Jagged) and receptors (Notch) are 
membrane-bound proteins, hence restricting activation to cells in direct contact, often 
termed ‘juxtacrine signalling’. Ligand binding triggers first the cleavage of Notch 
extracellular domain by ADAM protease, followed by Notch intracellular domain 
(NICD) by γ-secretase. Liberated cytosolic NICD fragments then translocate to the 
nucleus, where transcriptional complexes are formed to activate or repress genes 
downstream of Notch signalling (Figure 1.3). Importantly, NICD lacks DNA-binding 
capacity, thus its role as transcriptional co-factor relies on the partners in the 
complex, CSL (RBPJκ in mammals) and Mastermind (MAML). This sequence of 
events is regarded as ‘canonical Notch signalling’ (reviewed in Andersson et al., 
2011). Notch activation facilitates the expression of many Hes/Hey family basic 
helix-loop-helix (bHLH) proteins, and these factors can relay Notch functions by 
further modifying gene expression or by protein-protein interactions (reviewed in 
Fischer and Gessler, 2007).  
The Notch pathway is subject to extensive regulations, and several examples – by no 
means exhaustive – are discussed here. Notch is known to exhibit context-dependent 
positive or negative feedback through its target genes. Positive feedback, such as the 
activation of Notch receptor genes, reinforces the state of signal receiving cells and 
on tissue levels can lead to lateral inhibition (Greenwald, 1998). On the other hand, 
negative feedback via the expression of proteins antagonizing Notch signalling may 
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result in oscillatory behaviour (Hirata et al., 2002; Imayoshi et al., 2013). Apart from 
activating receptors in trans, Notch ligands can bind and inhibit receptors on the 
same cells, in a process called cis-inhibition (del Alamo et al., 2011). In addition, 
Fringe glycosyltransferases modify Notch receptors post-translationally to favour the 
binding of Delta ligands over Jagged (Panin et al., 1997; Visan et al., 2006). It is also 
well established that F-Box And WD Repeat Domain Containing 7 (FBXW7), the 
substrate recognition protein in SCF E3 ubiquitin ligase complex, is involved in fine 
tuning Notch signalling by degrading NICD (Carrieri and Dale, 2016; Matsumoto et 
al., 2011). Finally, Notch signalling components are increasingly shown to interact 
with pathways, for instance TGFβ and Wnt, further expanding its diversity of 
mechanisms (Andersson et al., 2011).   
The multitude of regulatory mechanisms confers great diversity to how Notch acts in 
different tissue and organ systems. For example, in inner ear development, Notch is 
involved in regulating different events in different processes (Kiernan, 2013). First, 
early widespread expression of Notch ligand JAG1 determines the field of sensory 
patches. In this case the Jag1 gene is activated by Notch, resulting in the lateral 
expansion of cells entering the sensory fate. Early misexpression of NICD converted 
non-sensory regions to sensory fate, indicating the pro-sensory function of Notch 
(Hartman et al., 2010). Later, cells in the sensory patches are sorted out into hair cells 
and supporting cells, the two sensory cell types in the inner ear, via the action of 
DLL1 and JAG2. This later wave of Notch dictates a salt-and-pepper pattern, in 
which ligand-expressing cells differentiate into hair cells where active Notch 
signalling in the adjacent cells leads to supporting cell fate (Kiernan et al., 2005). 
The difference in signalling outcome is due to ligand-dependent levels of Notch 
activation, since genes that require higher thresholds were activated by DLL1 but not 
JAG1 (Petrovic et al., 2014).  
What is more, Notch is dynamically deployed in the differentiation of pancreatic 
progenitors. Loss of Dll1, Rbpj or canonical target Hes1 in the early pancreatic 
primordium led to premature differentiation into the endocrine lineage, suggesting 
that Notch is a repressor of the endocrine fate (Apelqvist et al., 1999; Jensen et al., 
2000). However, constitutive expression of NICD prevented the differentiation of 
both endocrine and exocrine lineages, thus high levels of Notch appears to favour 
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progenitor self-renewal over differentiation (Murtaugh et al., 2003). It was thought 
that the decision to self-renew or undergo endocrine differentiation depends on a 
lateral inhibition mechanism, in which Neurogenin 3 (Ngn3)-expressing endocrine 
progenitors display Notch ligands, and Notch activity in the adjacent signal receiving 
cells in turn upregulates HES1 to repress Ngn3 and the endocrine potential (reviewed 
in Li et al., 2015). More recent studies have challenged this simple model. For 
example, Shih and colleagues have shown that two Notch targets, Hes1 and Sox9, are 
activated by high and intermediate levels of Notch signalling, respectively. 
Variations in Notch activity produced two subsets of progenitors: HES1+ SOX9+ and 
HES1- SOX9+. Although HES1 and NGN3 expression domains are mutually 
exclusive, in cells that experience intermediate Notch activity, SOX9 induces Ngn3 
to initiate endocrine differentiation (Shih et al., 2012). These observations suggest 
that, instead of an ON/OFF model, lineage decisions in pancreas development result 
from a graded response to Notch.  
Notch signalling is of crucial importance to T cell development in the thymus (Shah 
and Zuniga-Pflucker, 2014). In comparison, its role on TECs is less well understood, 
and the few published reports came to contradictory conclusions. Knockout mice of 
Notch pathway genes rarely survive to mid-gestation, hindering the examination of 
thymus development. An exception is the gene encoding the ligand Jagged2, the 
absence of which is associated with reduced medullary area in the thymus (Jiang et 
al., 1998). In culture, the addition of T cells or B cells overexpressing the Notch 
ligand DLL1 to thymocyte-depleted fetal thymus drastically improved the medullary 
architecture (Masuda et al., 2009). In contrast, Notch activity in adult TECs is 
enriched in a small subset of cTECs and appears repressed in mature mTECs by 
Histone Deacetylase 3 (HDAC3), and the overexpression of NICD by Foxn1Cre led to 
postnatal thymus hypoplasia and a severe block in mTEC differentiation (Goldfarb et 
al., 2016). Of note, fetal thymi were not examined in the Goldfarb study, therefore 
the phenotype could indicate either a developmental defect, or alternatively the 
cytotoxicity of long term NICD exposure. Since preliminary data in our lab 
confirmed the expression of Notch receptors, canonical targets and cytoplasmic 
modulators in primitive TEC progenitors (Vaidya et al, unpublished), we decided to 
thoroughly investigate the role of Notch signalling in TEC development.  
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1.7 Comments on markers 
It is the convention of the thymus field to conduct quantitative analysis using flow 
cytometry. Standard panels (Table 1.1 and 1.2) were designed in our lab for fetal and 
adult TEC flow analysis. The panels follow the rationale that there should be a 
distinction between live and dead cells (DAPI), lineage exclusion of non-TECs (LIN: 
CD45, CD31, TER119, CD11c), a pan-TEC marker (EPCAM), maturation markers 
(PLET1 and MHCII) and mTEC (UEA1) and cTEC (CD205/Ly51) markers. Note 
that for fetal analysis, CD205 is used to mark cTEC/TEPCs. This is switched to Ly51 
for adult cTECs as is the standard practice in the field. Additional markers used in 
this thesis (NOTCH1, active Caspase3 etc.) were stained in addition to the standard 
panels. Some flow markers are optional for the appropriate stage; for instance, the 
very early TECs (E10-12.5) express little or no MHCII or UEA1, hence the omission 
of these markers.  
The limited cellularity of fetal thymi occasionally precludes quantitative flow 
analysis. In order to overcome this challenge, as well as presenting tissue context, 
immunohistochemistry is often used as a complementary method to study TECs. 














Marker Expression Usage 
EPCAM Total TEC Always 




CD205 TEPC/cTEC E13.5 and 
older 
UEA1 mTEC E13.5 and 
older 
MHCII Functionally mature TECs E14.5 and 
older 
DAPI Dead cells Always 
Lineage (CD45, CD11c, 
CD31, Ter119) 



















Marker Expression Usage 
EPCAM Total TEC Always 
LY51 cTEC Always 
UEA1 mTEC Always 
MHCII Functionally mature TECs Always 
PLET1 Minority of mTECs. LY51+ PLET1+ 
TECs show progenitor activity 
Optional 
DAPI Dead cells Always 
Lineage (CD45, CD11c, 
CD31, Ter119) 





















Protein Expression Host 
species 
Pan-keratin (panK) General TEC  Rabbit 
K5 mTEC and CMJ Rabbit 
K8 General TEC, highly expressed in cTEC Rat 
K14 Comitted mTEC Rabbit 
CD205 TEPC/cTEC Rat 
PLET1 E12.5 TEPC and a subset of developing and 
mature TECs 
Rat 
Claudin 3 Apical side of 3PP, mTEC progenitor and 
mature mTEC 
Rabbit 
AIRE Mature mTEC, involved in tolerance induction Rabbit 


















The overarching aim of this thesis was to elucidate the role of Notch signalling in the 
development of the epithelial compartment in the thymus. To achieve this goal, I 
analyzed the TEC phenotypes of loss-of-function and gain-of-function models of 
Notch, as well as gene expression datasets. I then incorporated the data presented 





















Chapter II: Material and Methods 
 
2.1 Mice 
2.1.1 Animal facilities 
Wildtype (CBA and C57BL/6) and Foxn1Cre (Gordon et al., 2007), RbpjFL (Han et 
al., 2002), CBF1:H2B-Venus (Nowotschin et al., 2013), silent GFP (Gilchrist et al., 
2003) transgenic mice were housed in the animal unit at the MRC Centre for 
Regenerative Medicine (CRM), University of Edinburgh. The Ascl1 null mice 
(Guillemot et al., 1993) were housed at the animal unit at the National Institute for 
Medical Research (Mill Hill), Francis Crick institute. The mice used for experiments 
in Chapter V – Foxn1Cre, Rosa26loxP-STOP-loxP-NICD-IRES-EGFP (Murtaugh et al., 2003) 
and wildtype controls – were bred and housed at The École Polytechnique Fédérale 
de Lausanne (EPFL). Animal husbandry and treatments were carried out in 
accordance with Animal (Scientific Procedures) Act 1986.  
 
2.1.2 Mating 
Wildtype embryos used in this project were of CBAxC57BL/6 strain. CBA males 
were caged overnight with C57BL/6 females. Females were examined for vaginal 
plugs the next day, and the day the vaginal plug was found was taken as embryonic 
day 0.5 (E0.5).  
For transgenic mice: 
To produce Foxn1Cre; RbpjFL/FL conditional knockouts, Foxn1Cre/+; RbpjFL/+ males 
were crossed to RbpjFL/FL females. Conditional knockouts were produced in the 
progeny at approximately the expected Mendelian ratio of 1 in 4.  
To produce Ascl1-/- null embryos, Ascl1+/- heterozygous males and females were 
mated.  
To produce Foxn1Cre; Rosa26loxP-STOP-loxP-NICD-IRES-EGFP double transgenic embryos, 
homozygous Foxn1Cre/Cre males were mated to Rosa26NICD/NICD females. C57BL/6 
wildtypes were mated on the same day to generate controls. 
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2.1.3 Dissection of embryonic thymi  
At the appropriate stage, pregnant females were sacrificed and the uterus was 
collected into ice cold Phosphate-buffered saline (PBS) buffer made up from PBS 
tablets (Sigma). E12.5 and older embryos were decapitated, and embryonic thymi 
were then collected into cold PBS under a dissecting microscope. Tissue waste was 
disposed of according to local institute regulations.  
 
2.1.4 Embryo staging 
E10.5 embryos were staged by the number of somites developed. The plug date was 
used to calculate the age of E12.5 and older embryos.  
 
2.1.5 Genotyping 
2.1.5.1 Genomic DNA isolation 
Following microdissection of the embryonic thymus, embryonic tissue (head or 
appendage) was collected into Eppendorf tubes and digested overnight at 55°C in 
Embryo Buffer with 400μg/ml Proteinase K (Promega) in a shaking water bath. The 
next day the digested samples were incubated at 95 °C on a heat block for 10 minutes 
to deactivate Proteinase K. The samples were then centrifuged at 16.2g (13,000 
RPM) for 10 minutes to collect the genomic DNA in the supernatant.  
For genotyping FACS sorted TECs, the samples were resuspended in 25μl of 
200μg/ml Proteinase K diluted in water. The following program was used to digest 
cells and extract genomic DNA: 
55°C – 120min. 
95°C – 7 min. 




2.1.5.2 Tissue lysis buffer (‘Embryo Buffer’) 
10mM Tris-HCL, pH 8.3 (Roche) 
50mM Potassium Chloride (KCl) 
2.5mM Magnesium Chloride (MgCl2) 




2.1.5.3 PCR mix 
All genotyping carried out at the CRM used this reaction mix (Qiagen): 
3μl 10x Reaction Buffer 
6μl Q solution (optional on a reaction to reaction basis) 
0.5μl Taq enzyme 
0.5μl dNTP 
1μl Primer 1 (20μM) 
1μl Primer 2 (20μM) 
Genomic DNA (volume varies) 
Sterile water to a total volume of 30μl. 
 
2.1.5.4 Genotype analysis 
The genotyping of Foxn1Crex Rosa26loxP-STOP-loxP-NICD-IRES-EGFP embryos was 
performed by Dr. Ute Koch at EPFL, Lausanne. All other genotyping was done by 
Frances Stenhouse, Diana Peddie and myself at the CRM, University of Edinburgh.  
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The genomic DNA was amplified with the appropriate PCR program (section 2.9) 
and primer pair (section 2.10). The amplified PCR product was analyzed by gel 
electrophoresis.  
The composition of the gel was 2% agarose dissolved in x0.5 TBE buffer. 0.5μg/ml 
ethidium bromide was added to the gel allow the detection DNA. 5μl of 1X OrangeG 
loading dye was added to each amplified sample before loading. 10μl of 1kb ladder 
(Invitrogen) was also loaded to indicate the length of bands. The gels were run at 
100V for approximately 30 minutes and were visualized using a UV transilluminator 
at 312nm (Gene Flash, Syngene, UK).  
 
2.2 Tissue processing for analysis 
2.2.1 Tissue embedding and sectioning for immunohistochemistry  
Cultured explants, dissected thymi or embryo torsos were embedded in OCT (VWR) 
and snap frozen on dry ice. The OCT blocks were stored in a -80°C freezer and then 
cryo-sectioned into 7μm sections using a Leica cryostat at -15°C. Once the sections 
had been transferred to Polysine glass microscope slides (VWR), the slides were 
stored in a -80°C freezer until staining. 
 
2.2.2 Preparation of postnatal thymi for flow cytometry 
Thymi were cleaned up in RPMI 1640 medium (Gibco) prior to dissociation to 
remove blood, fat and connective tissue. The lobes were then cut up and dissociated.  
First, the tissue was dissociated in 2ml of 1.25mg/ml collagenase D (Roche) and 
0.05mg/ml DNaseI (Lorne) diluted in RPMI. After 15 minutes incubation the 
supernatant was transferred through a 70μm cell strainer (BD Falcon) to a 50ml 
Corning tube. Another 2ml of the dissociation buffer was added and the tissue was 
mechanically dissociated by pipetting in and out of the pipette tip. A total of three 
rounds of dissociation and collection were performed. The remaining pellet was 
further digested for 30 minutes in 1.25mg/ml collagenase/dispase (Roche) and 
0.05mg/ml DNaseI diluted in RPMI. The incubation temperature was 37°C for the 
duration of dissociation. 
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After this final dissociation step the whole sample was transferred to the collection 
tube. The tubes were centrifuged for 5 minutes at 284g (1500 RPM) at 4°C to pellet 
cells. The pellet was resuspended in PBS (Sigma) with 2% fetal calf serum (‘FACS 
wash’), and a small volume was diluted in FACS wash 100 times, and cells were 
counted using a BioRad cell counter and slides. Trypan blue was used to distinguish 
dead cells from live cells.  
Antibody staining for T cell analysis proceeded directly after cell count. However for 
TEC analysis, T cell depletion was first performed using anti-mouse CD45 
microbeads (Miltenyi). The beads were diluted 1/20 in FACS wash with 0.05mg/ml 
DNaseI, and used at the concentration of 5μl per 107 cells. After 15 minutes 
incubation on ice, with vigorous shaking midway through the incubation, the cell 
suspension was spun down for 5 minutes at 284g (1500 RPM) at 4°C and 
resuspended in 3ml of FACS wash with DNaseI. The cell suspension was then 
passed through a LS column (Miltenyi) fitted inside a strong magnet into a 15ml 
Corning tube on ice. Once the entire suspension had passed, 3ml of FACS wash with 
DNaseI was added in the columns to fully recover cells not bound by the magnetic 
beads. The Corning tubes were then centrifuged for 5 minutes at 284g (1500 RPM) 
and the pellet was resuspended in FACS wash with DNase. The samples can then be 
counted again, and TEC marker staining was carried out. 
 
2.2.3 Preparation of fetal thymi and cultured explants for flow 
cytometry 
Fetal tissue was collected into Eppendorf tubes containing 200-500μl of PBS with 
magnesium (Mg) and calcium (Ca) (Sigma). The tubes were spun down briefly to 
pellet the tissue. The supernatant was removed and replaced with 500-800μl of pre-
warmed (37°C) embryonic dissociation buffer, which consisted of 1.25mg/ml 
collagenase D, 1.4mg/ml hyaluronidase (Sigma) and 0.05mg/ml DNaseI diluted in 
PBS with Mg and Ca.  
The tissue was then dissociated in the buffer for 20 minutes at 37°C. Every four 
minutes the sample was mixed up and down with a pipette to aid the mechanical 
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detachment of cells. After 20 minutes the samples were spun down at 3.5g (6000 
RPM) for two minutes to pellet cells. The supernatant was collected in a 50ml 
Corning tube through a 70μm cell strainer. The pellet was resuspended and further 
incubated in 1X Trypsin (Invitrogen) for two minutes, and then collected in the 
Corning tube. The tubes were spun down at 284g (1500 RPM) for 5 minutes at 4°C 
to pellet cells. 
The pellet was resuspended in FACS wash with DNaseI. This cell suspension was 
then stained according to the antibodies panel for each individual experiment. 
 
2.3 Flow cytometry 
2.3.1 Antibody staining 
The antibodies used to stain cells were listed in section 2.10. Most flow antibodies 
targeting cell surface antigens were directly conjugated to fluorophores. The 
exceptions were PLET1 and UEA1.  
PLET1 antibody (1D4 supernatant) was not conjugated, therefore was stained alone 
first, and then with Goat anti-Rat Alexa 647 secondary antibody. Before other 
markers could be stained, a 15 minutes blocking in 20% rat serum was conducted.   
UEA1 is lectin which binds carbohydrate modifications on an unidentified cell 
surface protein on mTECs. UEA1 is conjugated with biotin, hence the secondary 
reagent streptavidin Brilliant Violet (BV) 650 was used. Primary UEA1 staining was 
performed singly, while streptavidin BV650 was applied along with the directly 
conjugated fluorescent antibodies. 
All cell surface antibody staining was carried out at 4°C for 15 minutes. For steps 
which involved incubation, FACS wash with DNaseI were used as buffer. Between 
two staining steps, 2ml of FACS wash was added to the cell suspension, and the 
samples were centrifuged at 284g (1500 RPM) for 5 minutes at 4°C to wash the cells. 
The supernatant was removed, and the pellet was resuspended in the buffer for the 
next step.  
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After surface markers had been stained, the samples were washed twice in FACS 
wash and DAPI (1/20000, Molecular Probes) was added to distinguish live cells 
(DAPI-) from dead cells (DAPI+).  
For intracellular staining (Foxp3 and active Caspase3), cell surface markers were 
stained as above. The cells were then washed twice in PBS and stained with 
fluorescent viability dye eFluor™ 450 (Thermo) diluted 1/1000 in PBS for 30 
minutes. Then the cells were fixed in Fixation/Permeabilization buffer (eBioscience) 
for 30 minutes, before staining with the antibodies against intracellular markers 
diluted in Perm buffer (eBioscience) for 30 minutes. After the intracellular staining, 
samples were washed in FACS wash twice before flow analysis.   
 
2.3.2 Staining controls 
Around 10% of cells were set aside for controls. In the cases where positive and 
negative populations were poorly resolved, fluorescence minus one (FMO) controls, 
in which cells were stained for all antibodies except for the one in question, were 
also established. Compensation for spectrum overlap was calculated by the software. 
For this purpose, Ultracomp beads (Invitrogen) stained with single fluorophores were 
run on the flow cytometer to determine the spectrum of each fluorophore. For DAPI 
and fluorescent viability dye, single stains were done on cells.  
 
2.3.3 Performing analysis 
Flow analyses were run on BD LSR Fortessa (4-laser and 5-laser system). Unstained 
and full stained sample were analyzed to determine suitable voltages, followed by 
single stained samples to calculate compensation. FMO and experimental samples 
were then recorded. Finally, the compensation matrix was examined and inaccuracies 
were manually corrected.  
Flow cytometry data were analyzed using FlowJo Version 9.7.6. All gating strategies 




2.3.4 Cell sorting  
Cell sorting was performed on a BD FACS Aria II under my instruction, by the CRM 
Flow Cytometry Facility staff Dr. Fiona Rossi and Dr. Claire Cryer, and by Dr. 
Romain Bedel and Dr. Andreia Ribeiro at the University of Lausanne, Epalinges. 
Compensation was performed before sorting.  
 
2.4 RT-qPCR 
2.4.1 Cell sorting  
Small cell number (50-200 cells) FACS sorting was performed to isolate fetal TEC 
populations. Cells were directly sorted into PCR tubes containing the Reaction 
Buffer. Reaction Buffer, which consisted of 10μl CellsDirect 2X Reaction Mix (Cells 
Direct kit, Invitrogen) and 0.2μl SUPERase-In (Applied Biosystems). Sorted samples 
were briefly spun down and frozen on dry ice. Total EPCAM+ TECs of equal number 
were sorted and used as controls. The sorted samples were stored in a -20°C freezer 
for no longer than one week before pre-amplification of candidate genes.  
 
2.4.2 Primer design 
Primer pairs for genes of interest were designed using the Roche Universal Probe 
Library (UPL) assay design software. One of the intron spanning designs with the 
highest score was selected. The primers (standard DNA oligonucleotides) were 
ordered from Sigma.    
 
2.4.3 Pre-amplification 
2.4.3.1 PreAmp Master Mix  
5μl Primer Mix (pooled Forward and Reverse primers for all test genes, each diluted 
to 200nM in water)  




Note that the 2X Reaction Mix, into which the cells were sorted, contained the 
required PCR buffer, therefore it is not provided in the PreAmp Master Mix. 
For negative controls (without reverse transcriptase), the SuperScriptIII enzyme was 
substituted with Taq (Qiagen). Up to 32 primer pairs were multiplexed for each RT-
qPCR analysis. 
 
2.4.3.2 PreAmp reaction 
10μl of PreAmp Master Mix was added to the sorted samples. For negative controls 
the Taq substituted Master Mix was added.  
The pre-amplification PCR program (section 2.9) was run to first reverse transcribe 
cDNA and amplify the DNA fragments targeted by the primer pairs. The amplified 
samples were used directly for RT-qPCR analysis or stored in a -20°C freezer until 
analysis. 
 
2.4.4 Quantitative PCR 
2.4.4.1 Loading qPCR Master Mix 
For each well of the 384-well plate (Roche), the following Master Mix (7.5μl) was 
loaded.  
5.0μl 2X Master Mix (Roche) 
0.1μl UPL probe (Roche) 
0.225μl 20μM Forward+reverse primers 
2.175μl Water 
Each gene/population combination was loaded in triplicates.  
 
2.4.4.2 Loading cDNA samples 
The pre-amplified cDNA samples were diluted in sterile water to the concentration 
required. Usually for 16 genes 120μl water was added to 20μl pre-amplified sample.  
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2.5μl of diluted cDNA was loaded to each well of the plate. As the Master Mix was 
loaded first, pipette tips were changed between each loading.  
 
2.4.4.3 Real time fluorescence detection 
The loaded 384-well plate was sealed with a transparent film (Roche). The plate was 
then centrifuged at 170g (1000 RPM) for 60 seconds to mix the Master Mix with the 
cDNA. The PCR reaction was run on LightCycler 480-II (Roche) using the RT-
qPCR program in section 2.9.  
The Cq value of each well was calculated on the LightCycler 480-II software using 
the function ‘Abs. Quant/2nd Derivative Max’. The values were exported as text files.  
 
2.4.5 Calculation of normalized gene expression levels 
If no great variation was observed, the numerical average of the triplicate Cq values 
was calculated. If, however, one of the three values deviated substantially (by larger 
than 1), this datum was discarded, and the other two values were used to calculate the 
average. The average Cq values were used to calculate the initial quantity of cDNA 
on the assumption that fluorescence emitted by the probe doubles in each PCR cycle. 
The geometric mean of three housekeeping genes (Hprt, Hmbs and Ywhaz) for each 
cDNA sample were taken as baseline. The relative expression value of all other 
genes was normalized to this baseline.  
 
2.5 RNA sequencing  
2.5.1 Cell sorting 
Prior to sorting, ethanol and subsequently sterile water were run through the BD Aria 
II sorter. The sorting area was cleaned with 70% IMS and RNaseZap (Ambion). 
100 TECs per population were sorted into 4μl of Smartseq2 buffer in sterile PCR 
tubes. Rbpj conditional knockout and littermate control TECs were collected at the 
CRM, University of Edinburgh. Inducible NICD TECs were collected at University 
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of Lausanne, Epalinges. Each transgenic embryo was genotyped retrospectively. 
Sorted samples were briefly spun down and frozen on dry ice. These samples were 
kept in a -80°C freezer until library preparation.  
Tissue preparation for FACS was as described above. The antibody panel used for 
cell surface marker staining was: 
PLET1 – AlexaFluor 647 
EPCAM – PE 
Lineage (CD45, CD11c, CD31 and TER119) – PerCP Cy5.5 
Viability – DAPI 
 
2.5.2 Smartseq2 buffer 
2μl 0.2% Triton X-100 (Sigma) with RNase inhibitor (1:20, Takara) 
1μl 10μM oligo-dT primer (Biomers.net)  
1μl 10mM dNTP mix (Thermo) 
The Smartseq2 buffer was prepared as described by Picelli and colleagues (Picelli et 
al., 2013). Triton X-100 was diluted in sterile water (Gibco).  
The oligo-dT primer sequence was 5’-
AAGCAGTGGTATCAACGCAGAGTACT30VN-3’. 
 
2.5.3 Precautions regarding buffer preparation 
Preparation of the buffer was carried out in a UV hood at the CRM, Edinburgh, and 
in a tissue culture hood at EPFL, Lausanne. In the case of the UV hood, UV lamp 
was kept on for 60 minutes to sterilize the handling area. Surfaces inside the hoods 
were cleaned with 70% ethanol, DNA-OFF (Takara Bio), and RNaseZap (Ambion). 




2.5.4 Library preparation and sequencing 
Samples were shipped on dry ice to the Weatherall Institute of Molecular Medicine, 
University of Oxford for library preparation by Dr. Neil Ashley. 75bp paired-end 
sequencing on Illumina HiSeq4000 was overseen by Dr. Jerome Nicod at the 
Wellcome Trust Centre for Human Genetics, University of Oxford.  
 
2.6 Immunohistochemistry (IHC) 
2.6.1 Staining protocol 
For regular TEC markers (pan-keratin, K5, K8, K14, CD205, CLDN3, AIRE, PLET1 
and UEA1), the following standard protocol was adopted. 
Glass slides were retrieved from the -80°C freezer and warmed to room temperature. 
Intact sections were identified under a compound microscope. Sections were then 
fixed for two minutes in acetone (Fisher) which had been pre-chilled in a -20 °C 
freezer. The selected sections were ringed with hydrophobic pen (Vector 
Laboratories) and air dried for 30 minutes.  
Sections were blocked in 100μl of 5% serum of the secondary antibody species 
diluted in 1X PBS (made up from Sigma tablets) for 30 minutes. After incubation the 
blocking solution was removed and replaced by 100μl of primary antibodies diluted 
in 1% secondary serum in PBS. Sections were stained with primary antibodies or 
IgG controls for 60 minutes at room temperature. Primary antibody cocktail was 
removed, and the sections were washed three times in PBS-Tween (PBS with 0.1% 
Tween-20) for five minutes. Afterwards, each section was stained at room 
temperature for 45 minutes with 100μl of fluorescent secondary antibodies made up 
in 1% secondary serum. The sections were shielded from light during his staining 
step. Three washes of five minutes in PBS-Tween were done before DAPI (1:1000 in 
water) was applied to the sections for approximately one minute. The slides were 
dipped briefly in distilled water and air dried. A drop of Vectorshield hard set 
mounting medium for fluorescence (Vector Laboratories) was applied to each 
section. Slide mounting was conducted by gently lowering the coverslip onto the 
slides. Mounted slides were kept at 4°C and shielded from light until imaging.  
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2.6.2 Adjustments for specific antibodies 
For antibodies targeting NOTCH2, NOTCH3 and JAGGED1, sections were blocked 
with 10% goat serum for 60 minutes and stained with these primary antibodies alone 
in a moist staining chamber overnight at 4°C. On the second day the slides were 




Leica SP2, SPE and SP8 confocal microscopes were used to image 
immunofluorescence. Gain and offset for each fluorescence channel were adjusted 
prior to imaging based on stained sections and negative controls. Exported images 
were analyzed using Fiji or Photoshop. Only brightness and contrast of the images 
were altered.  
 
2.6.4 Image quantitation (Chapter IV) 
Every E14.5 thymic sections were collected and stained for image analysis on Fiji. 
The thymic area on each section was designated as the number of pixels defined by 
DAPI. A threshold was manually set for each section, above which the pixels were 
regarded as positive for the marker. ‘Percentage positive for a marker’ is defined as 
pixels positive for that marker divided by pixels that composed the thymic area. Each 
datum used for statistical analysis was the total percentage positive for the marker in 
a whole embryonic thymus.   
 
2.7 Fetal thymus tissue culture (FTOC) 
2.7.1 Culturing third pharyngeal pouch (E10.5) and embryonic 
thymic tissue (E12.5 and E14.5) 
The culture was set up in 48-well plates (Figure 2.1A). A thin layer of matrigel 
(Corning) was coated onto the bottom of the wells. 300μl of N2B27 medium 
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supplemented with 20ng/ml human FGF8 (PeproTech) and 20ng/ml murine BMP4 
(PeproTech) was then added to each well.   
Microdissected tissue was transferred to plates using forceps and incubated at 37°C 
in 5% carbon dioxide. In the first 24 hours of culture the explants would submerge in 
the medium and mesenchymal cells would form attachment with the matrigel 
beneath. The culture medium was changed daily for the duration of the culture, 
unless otherwise indicated. 
 
2.7.1.1 N2B27-based ‘TEPC medium’  
N2B27 medium:  
1X DMEM/F12-N2 (Gibco) 
1X Neurobasal medium-B27 (Gibco)  
[DMEM/F12-N2 and Neurobasal-B27 were mixed at 1:1 ratio] 
1mM L-Glutamine (Invitrogen) 
0.114mM β-mercaptoethanol (Sigma) 
Supplemented with:  
20ng/ml murine BMP4 (PeproTech) 
20ng/ml human FGF8 (PeproTech) 
1μg/ml heparin (Sigma) 
Penicillin (100U/ml) & streptomycin (100μg/ml) (Invitrogen) 





2.7.1.2 Matrigel coating  
Upon arrival, matrigel was thawed on ice and divided into 100μl aliquots in 
Eppendorf tubes. These tubes were frozen and stored in a -20°C freezer. Before 
coating, matrigel aliquots were thawed on ice for at least 30 minutes.  
P200 pipette tips were cooled on ice before being used to transfer matrigel from 
Eppendorf tubes to 48-well plates. For thin coating, 90μl of matrigel was transferred 
to cover the surface of each well. After approximately 10 seconds, matrigel was 
removed, leaving only a thin surface at the bottom of the well.  
 
2.7.2 Culturing older embryonic thymic tissue (E15.5 and E16.5) 
The culture was set up in 24-well plates (Figure 2.1B). 600μl of ‘FTOC medium’ 
was added to each well. An isopore membrane filter (Millipore) was placed at the 
air-liquid interface. Microdissected tissue was transferred onto the membrane with 
forceps. The plates were then incubated for three days at 37°C with 5% carbon 
dioxide. The medium was not refreshed during incubation. 
 
2.7.2.1 FTOC medium 
DMEM (Gibco) 
10% Fetal Calf Serum (FCS) (Life Technologies) 
2mM L-Glutamine (Invitrogen) 
Penicillin (100U/ml) & streptomycin (100μg/ml)  
Additional reagents: 1.35 mM 2-deoxyguanosine (dGuo, Sigma), 500 ng/ml murine 
RANK ligand (PeproTech) and DAPT (Tocris) were included as indicated. Where 






Figure 2.1 FTOC experimental set-up for younger (A) and older (B) 
embryonic thymic tissue. (A) E10.5 third pharyngeal pouches (3PPs) or 
E12.5/14.5 thymic lobes were submerged in TEPC medium on a thin layer of 
matrigel. 300μl of medium was transferred to each well in the 48-well plate. A 
maximum of three explants were cultured in each well. (B) E15.5/16.5 thymic 
lobes were cultured on filter membrane over FTOC medium. 600μl of 
medium was transferred to each well in the 24-well plate. For DAPT 
treatment 3 wildtype lobes were placed in each well. For RANKL stimulation 
of transgenic thymi, each pair of thymic lobes from an individual embryo was 





2.8.1 Wet lab data 
The raw data used for quantitation are presented in full in appendices. All error bars 
on histograms were plotted with standard deviations.  
Statistical tests were carried out using the GraphPad Prism 7.02 software. For data 
where N is 3 or larger, pairwise comparisons were conducted using unpaired, two-
tailed Student’s T-test. For multiple comparisons one-way ANOVA test (two tailed) 
was performed, as appropriate for normally distributed data. For wildtype FTOC 
data, Tukey’s test was used to generate multiple comparison matrix as N was 
uniform for all culture conditions. For the transgenic FTOC experiments N could not 
be controlled, thus a stepwise method (Holm-Sidak) was used to determine P-values 
in multiple comparisons. P<0.05 was taken as significant.  
 
2.8.2 RNA-seq data 
Bioinformatics analysis of the RNA-seq data was performed by Anastasia Kousa 
(CRM, University of Edinburgh).  
Briefly, raw data were trimmed to remove adaptor contamination and low quality 
reads. Sequence reads that passed quality control were aligned with STAR mouse 
genome assembly (GRCm28 – Ensembl 87) and assigned to genes. Differential 
expression analysis was performed on R using the LIMMA package and voom from 
Bioconductor. A threshold of FDR ≤ 0.05 was set as significant between the different 
datasets. Pathway analysis was then analyzed using Gene Set Enrichment Analysis 
(GSEA). Pathways were defined as enriched where FDR ≤ 0.25 (the default 







2.9 PCR programs 
2.9.1 Genotyping Foxn1Cre allele  
94°C – 3min. 
30 cycles of: 94°C – 15s; 63°C – 15s; 72°C – 1min. 
72°C – 10 min. 
4°C – ∞. 
 
2.9.2 Genotyping Rbpj+, RbpjFL and RbpjDEL alleles 
94°C – 5min 
30 cycles of: 94°C – 30s; 56°C – 30s; 72°C – 1min. 
72°C – 10 min. 
4°C – ∞. 
 
2.9.3 Genotyping silent GFP allele  
94°C – 5min. 
30 cycles of: 94°C – 30s; 59°C – 30s; 72°C – 1min. 
72°C – 7 min. 
4°C – ∞. 
 
2.9.4 Genotyping CBF1:H2B-Venus allele  
94°C – 5min. 
30 cycles of: 94°C – 30s; 59°C – 30s; 72°C – 1min. 
72°C – 10 min. 
4°C – ∞. 
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2.9.5 Genotyping Ascl1+ and Ascl1- alleles  
94°C – 5min. 
35 cycles of: 94°C – 1min; 60°C – 1min; 72°C – 1min. 
72°C – 10 min. 
4°C – ∞. 
 
2.9.6 Genotyping Rosa26NICD allele 
94°C – 2min. 
35 cycles of: 94°C – 30s; 60°C – 30s; 72°C – 30s. 
72°C – 10 min. 
4°C – ∞. 
 
2.9.7 Pre-amplification of mRNA  
50°C – 15min. 
95°C – 2min. 
18 cycles of: 95°C – 15s; 60°C – 4min. 
4°C – ∞. 
 
2.9.8 RT-qPCR  
95°C – 5min. 
45 cycles of: 95°C – 10s; 60°C – 20s*. 
40°C – 10s. 
(*The point at which fluorescence was quantified in each cycle.) 
53 
 
2.10 Tables  
 
2.10.1 Primary antibodies for IHC 
Antigen Host species Clone Supplier 
Pan-keratin Rabbit Z0622 DAKO 
Cytokeratin5 (K5) Rabbit AF138 BD 
Cytokeratin8 (K8) Rat Troma1 DSHB 
Cytokeratin14 (K14) Rabbit AF64 Covance 
Claudin3 (CLDN3) Rabbit AB15102 Abcam 
NOTCH2 Rabbit 25-255 Santa Cruz 
NOTCH3 Rabbit AB23426 Abcam 
JAG1 Rabbit H114 Santa Cruz 
AIRE Rabbit M300 Santa Cruz 
PLET1 Rat 1D4 Homemade 
CD205 Rat NLDC-145 AbD Serotec 
UEA1 Biotin #L-1060 Vector 
Rat IgG isotype Rat RTK4530 BioLegend 
Rabbit IgG isotype Rabbit #550875 BD 
 
2.10.2 Secondary antibodies for IHC 
Antibody Supplier Catalogue 
number 
Goat anti-rabbit Alexa488  Invitrogen #A11034 
Goat anti-rat Alexa 647 Life Technologies #A21247 
Goat anti-rat Alexa568 Invitrogen #A11077 







2.10.3 Flow cytometry antibodies 
Antigen Conjugate Clone Supplier 
EPCAM APC G8.8 eBioscience 
EPCAM PE G8.8 Biolegend 
EPCAM APCCy7 G8.8 Biolegend 
MHCII PE M5/114.15.2 BD Pharmingen 
MHCII APCeFluor780 M5/114.15.2 eBioscience 
MHCII PECy7 M5/114.15.2 eBioscience 
CD45 APC 30-F11 eBioscience 
CD45 APCeFluor780 30-F11 eBioscience 
CD45 PerCP Cy5.5 30-F11 eBioscience 
NOTCH1 APC 22E5 eBioscience 
UEA1 Biotin #L-1060 Vector 
CD205 PECy7 205yetka eBioscience 
LY51 PE 6C3 eBioscience 
CD4 BV650 RM4-5 Biolegend 
CD4 PECy7 RM4-5 eBioscience 
CD8a PerCP Cy5.5 53-6.7 eBioscience 
CD25 PE PC61.5 eBioscience 
CD44 APC IM7 Biolegend 
CD11c PerCP Cy5.5 N418 Biolegend 
CD31 PerCP Cy5.5 390 Biolegend 
TER119 PerCP Cy5.5 Ter119 eBioscience 
B220 FITC RA3-6B2 eBioscience 
TCRβ PerCP Cy5.5 H57-597 Biolegend 
CCR6 PECy7 G034E3 Biolegend 
FOXP3 PE FJK-16S eBioscience 
PLET1 None 1D4 Homemade 
Caspase3 PE #51-68655X BD Pharmingen 




2.10.4 Genotyping primers 
Protocol Orientation Sequence 
Foxn1Cre Forward (F) 5'-GACCAGGTTCGTTCACTCATGG-3' 
 
Reverse (R) 5'-CCTTAGCGCCGTAAATCAATCG-3' 




RbpjFL F 5'-GTTCTTAACCTGTTGGTCGGAAAC-3' 
 
R 5'-GGGCTGCTAAAGCGCATGCT-3' 
RbpjDEL F  5'-CCTTGGTTTGTTGTTTGGGTT-3' 
 
R  5'-GTGGCTCTCAACTCCCAATCGT-3' 
sGFP F 5'-ACATGGTCCTGCTGGAGTTC-3' 
 
R 5'-TCAGGTTCAGGGGGAGGT-3' 
Rosa26NICD F 5'-AAAGTCGCTCTGAGTTGTTAT-3' 
 
R  5'-GCGAAGAGTTTGTCCTCAACC-3' 
Rosa26WT F 5'-AAAGTCGCTCTGAGTTGTTAT-3' 
 
R  5'-GGAGCGGGAGAAATGGATATG-3' 
CBF1:H2B-Venus F 5'-AAGTTCATCTGCACCACCG-3' 
 
R 5'-TGCTCAGGTAGTGGTTGTCG-3' 
Ascl1WT F  5'-CTCCGGGAGCATGTCCCCAA-3' 
 
R 5'-CCAGGACTCAATACGCAGGG-3' 










2.10.5 RT-qPCR primers and UPL probes 
Gene Orientation Sequence Probe 











































































2.10.6 Tissue culture growth factors 




Recombinant murine BMP4 PeproTech #315-27 10mM citric 
acid in water 
Recombinant murine RANK 
ligand 
PeproTech #315-11 Water 
Recombinant human FGF8 PeproTech #100-25 Water 
DAPT Tocris #2634 DMSO 
2'-Deoxyguanosine 
monohydrate 












Chapter III Candidate gene expression in early fetal thymus 
 
In order to theorize the functions of Notch signalling in regulating fetal TEC 
development, I first determined if the pathway is active in the early thymic 
epithelium. To this end, E12.5-14.5 TECs were characterized using RT-qPCR, 
immunohistochemistry (IHC), and a Notch reporter line. For gene expression, I 
specifically analyzed the expression pattern of Notch receptors, ligands, canonical 
targets and modulators, since these genes provide clues as to which cells are 
receptive to signalling, and which cells are actively transducing. As the early 
rudiments lack obvious histological features, rather than the more conventional in 
situ hybridization approach, populations of TECs were FACS sorted for mRNA 
analysis based on established cell surface markers.  
 
3.1 Expression profile of mRNA and proteins  
To detect Notch activity in the early thymus rudiments, RT-qPCR was performed for 
Notch pathway components, target genes and potential regulators. E12.5, E13.5 and 
E14.5 TEC populations were studied. These are crucial stages in the differentiation 
of early TEPCs, since relevant literature suggests that the restriction of some bipotent 
TEPCs to the medullary fate occurs during this time window (Hamazaki et al., 2007; 
Rossi et al., 2006).   
The standard FACS sorting markers panel (EPCAM, PLET1, CD205, UEA1, 
MHCII, DAPI and lineage) for fetal TECs can be found in Table 1.1 in Chapter 1. 
For the stages I characterized, some of the markers were omitted due to their low 
frequency or levels of expression. 
For E12.5 and E13.5 samples, in addition to viability marker DAPI and lineage 
exclusion markers, only EPCAM and PLET1 were stained to highlight cell 
populations (Fig 3.1).  For E12.5 TECs, their EPCAM+ PLET1+ phenotype is 
relatively homogeneous and was thus sorted as a single population. PLET1 
expression is gradually downregulated in TEC differentiation, and PLET1 
heterogeneity is first apparent at E13.5 (Nowell et al., 2011). Since very few E13.5 
59 
 
TECs are positive for the mTEC marker UEA1, I decided to separate E13.5 TECs 
into PLET1hi and PLET1lo populations, which represent less and more differentiated 
TECs, respectively.  
For E14.5 TECs, I used EPCAM, PLET1, UEA1, lineage and DAPI as the FACS 
sorting panel. The increased frequency of UEA1-expressing TECs allowed these 
prospective mTECs to be isolated separately. As the mature cTEC marker CD205 
also marks some bipotent TEPCs at this developmental stage (Baik et al., 2013), it 
was not used to facilitate cell sorting. Instead, the UEA1- E14.5 TECs were further 
divided into PLET1+ and PLET1- fractions, again to represent more and less 
primitive cTEC/TEPC subsets.  
200 cells were isolated for each population and analyzed by RT-qPCR. The sorting 
strategy is summarized in Appendix 8.1.1. Sorted samples are shown with asterisks 









Figure 3.1 The FACS sorting strategy for E12.5, E13.5, and E14.5 TEC 
populations analyzed by RT-qPCR. Positive and negative gates were 
established using FMO controls for UEA1 and PLET1. Gating strategy 
preceding the ‘total TECs’ population for all fetal TEC analyses is shown in 






















3.1.1 mRNA expression 
I first analyzed the expression pattern of all Notch family receptors and ligands. Of 
these, the expression of Notch1, Notch2, Notch3, Dll4 and Jagged1 (Jag1) was 
detected at the stages analyzed (Fig 3.2), whereas the levels of Notch4, Dll1 and Jag2 
were negligible. Notch1 and Notch2 were both enriched by two-fold specifically in 
the E14.5 UEA1+ mTECs compared to E14.5 UEA1- populations. In comparison 
Notch3 expression was initially high in E12.5 TECs, and decreased over the next two 
days, with the rate of decrease being noticeably more rapid in PLET1- cells. Jag1 
exhibited a very similar expression pattern to Notch3, but is distinct from Dll4, which 
was enriched in E13.5 PLET1- and E14.5 UEA1- populations. Dll4 is an established 
FOXN1 target (Zuklys et al., 2016) and the correlation in their temporal expression 
pattern, especially in E14.5 TEC subsets, reflects this relationship.  
The expression of several Hes/Hey genes was also addressed (Fig 3.2), as their 
expression is often associated with Notch activity (Fischer and Gessler, 2007). Hes1 
and HeyL were expressed most highly in E12.5 TECs and went down with 
developmental progression. HeyL also showed a slight enrichment in E14.5 mTECs. 
The expression of the recently identified FOXN1 target Hey1 (Zuklys et al., 2016) 
was essentially unchanged during the timeframe examined. In contrast, Hes6 
expression fell from E12.5 to E14.5 specifically in the emerging mTECs (Fig 3.3). 
HES6 has been shown to antagonize the downstream effectors of Notch (Gratton et 
al., 2003), therefore its downregulation may reflect a fine-tuning mechanism to 
maintain Notch signalling strength in early mTECs. What is more, Hes5 was not 
found to be expressed by fetal TECs. I established in Chapter VI that the expression 
of Hes1 and HeyL is sensitive to Notch perturbation. Therefore, it seems that Notch 
activity is downregulated from E12.5 to E14.5.  
Several other genes of interest were characterized similarly using RT-qPCR (Fig 
3.3). Achaete-Scute Complex-Like 1 (Ascl1) encodes a bHLH transcription factor 
and is often repressed by Notch (Axelson, 2004). Ascl1 is uniquely and strikingly 
activated in the E14.5 mTEC population, suggesting that it is a marker of early 
mTECs, or that it plays an active role in mTEC development. Fbxw7 expression at 
E13.5 was enriched in the PLET1- fraction and by E14.5 the mRNA is almost 
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depleted in mTECs. FBXW7 has been implicated in the degradation of NICD 
(Carrieri and Dale, 2016) and is also a FOXN1 target (Zuklys et al., 2016). 
Moreover, ID proteins are bHLH factors often associated with BMP signalling 
(Ruzinova and Benezra, 2003), and can also enhance Hes1 expression (Bai et al., 
2007). Id1 was found to be expressed highly in E12.5 TECs and indiscriminately 
downregulated in the next two days, likely indicating the waning strength of BMP 
signalling.   
The agarose gels showing the PCR products can be found in Appendix 8.3.  
 
3.1.2 Protein expression 
Flow cytometry and IHC were also used to elucidate the protein expression of a 
number of Notch receptors and ligands. NOTCH1 expression was quantified in three 
E13.5 litters using flow cytometry, as a good antibody was available, with each litter 
pooled to maximize the abundance of UEA1+ mTECs (Fig 3.4A). The proportion of 
NOTCH1+ cells among mTECs was 51.5% ± 8.4%, significantly higher than 24.7% 
± 10.4% among TECs that did not express definitive mTEC marker. This may reflect 
enriched receptiveness of emerging mTECs for NOTCH1 activation. 
In the absence of good flow antibodies, I undertook IHC to study the expression of 
NOTCH2, NOTCH3 and JAG1. Like NOTCH1, NOTCH2 and JAG1 also largely 
co-stained with UEA1 on E14.5 thymic sections, whereas NOTCH3 was broadly 












Figure 3.2 mRNA expression of candidate genes in fetal TEC populations. 
E12.5, E13.5 and E14.5 populations were presented in white, grey and black 
bars, respectively. The E14.5 mTEC population (UEA1+) was shown in dotted 
pattern to distinguish it from E14.5 non-mTEC populations.  
For Foxn1, Notch1, Ascl1, Fbxw7, Hes1, Hes6 and Hey1, N=6 for E12.5 and 
E13.5 populations, and N=3 for E14.5 populations.  
For Notch2, N=5 for E12.5 and E13.5 populations, and N=3 for E14.5 
populations.  
For Id1, Jag1, Dll4, Notch3 and HeyL, N=3 for all populations.  












Figure 3.3 mRNA expression of candidate genes in fetal TEC populations 















Figure 3.4 Protein expression of NOTCH1, NOTCH2, NOTCH3 and JAG1 in 
embryonic TECs.  
(A) The expression of NOTCH1 in E13.5 TECs, divided by UEA1 expression. 
Each independent litter of embryos was used to generate a data point used 
to quantify the percentage UEA1+ or UEA1- TECs expressing NOTCH1. N=3.  
(B-D) Immunohistochemistry staining of NOTCH2 (B), NOTCH3 (C) and 
JAG1 (D) on E14.5 thymus sections. Counter stained with mTEC marker 




















3.2 Analysis of a Notch reporter line 
To further characterize Notch activity in fetal TECs, I also analyzed CBF1:H2B-
Venus thymi at E14.5. The logic of the reporter line is as follows (Nowotschin et al., 
2013). When NICD-RBPJ complex binds the CBF1 Response Elements inserted 
before the SV40 promoter, expression of the histone H2B-Venus fusion protein is 
activated. Cells with a recent history of Notch activity could therefore be identified 
through the detection of Venus fluorescence. 
At E14.5, the mTEC and cTEC populations were clearly identifiable based on the 
expression of UEA1 and CD205, although the CD205+ subset may still contain some 
bipotent TEPCs (Figure 3.5A). At this stage about 5% of total TECs were Venus+. A 
striking disparity in Venus expression was found between prospective mTECs and 
cTECs. Whereas half of mTEC (47.7% ± 6.7) were Venus+, only a small minority of 
CD205+ cTECs/TEPCs (3.4% ± 1.1%) expressed Venus (Figure 3.5A). There was 
also heterogeneity of Venus expression in terms of MHCII profile. When total TECs 
were divided into the more primitive MHCII- and the more differentiated MHCII+ 
populations, a higher proportion of MHCII+ cells were Venus+ (8.4% ± 1.9% 
compared to 2.4% ± 1.4%) (Figure 3.5B).  
While analyzing the Venus expression in adult TECs, I noted that the frequency of 
Venus+ TECs was considerably higher than that reported by Goldfarb and colleagues 
using a different reporter strain (Goldfarb et al., 2016). The CBF1:H2B-Venus line is 
not without flaws, including the slow turnover of H2B-Venus proteins and the 
fixation of transgene expression in cells no longer signalling (Hadjantonakis, 
personal communications). Thus, caution shall be exercised in the interpretation of 















Figure 3.5 Enrichment of Notch signalling activity in E14.5 mTECs.  
CBF1:H2B-Venus reporter in E14.5 TEC subsets, N=4. 
(A) Venus expression in UEA1+ CD205- prospective mTEC and UEA1- 
CD205+ prospective cTEC/TEPC (‘cTEC’) populations.  























The earliest mTECs (E14.5) are enriched in the expression of Notch1, Notch2 and the 
ligand Jag1 compared to their UEA1- non-mTEC counterparts. The correlation is 
present not only in respect with mRNA, but also holds for protein expression. This 
suggests that emerging mTECs are more receptive to Notch activation, while also 
capable of propagating Notch signal to neighbouring cells. Single cell RT-qPCR or 
RNA-seq will be required to establish whether Jag1 and Notch receptor genes 
broadly co-express in early mTECs.  
Notch3, on the other hand, appeared more robustly transcribed in E12.5 primitive 
TEPCs, and is downregulated with developmental progress. Interestingly, very little 
NOTCH3 protein expression was found in E14.5 thymi, indicating that it had ceased 
to be an important receptor. NOTCH3 molecular structure deviates considerably 
from NOTCH1 and NOTCH2 (reviewed in Bellavia et al., 2008), and it has been 
shown to more weakly activate Notch targets in certain circumstances (Beatus et al., 
1999). It is currently unclear whether the three Notch receptors drive different levels 
of signalling in TECs, or indeed what the functional relevance is, but given what is 
understood regarding Notch signalling, one of a few possibilities is likely. As Notch3 
was associated with earlier progenitors, and Notch1 and Notch2 more with mTECs, 
these receptors may act on separate TEC lineages. If we assume that the signalling 
strength is increased by switching from NOTCH3 to NOTCH1 and NOTCH2, this 
shift may indicate higher levels of Notch signalling thresholds in mTECs than 
TEPCs. Finally, the expression of Notch1 and Notch2 are Notch-dependent in E14.5 
TECs (Chapter VI), raising the possibility that these receptors may be involved in 
positive feedback to preserve the competence for extended Notch signalling in 
mTECs, whereas NOTCH3 may initiate the process in the first place.  
As far as the expression of putative Notch targets is concerned, data documented 
here and previously (Vaidya, unpublished) support the notion that Notch is already 
active in TEPCs and that the pathway is dynamically regulated. Of note, while Notch 
reporter CBF1:H2B-Venus revealed that Notch activity is more prevalent in E14.5 
mTECs compared to cTEC/TEPCs, the expression of Hes1 and Hey1 was not 
considerably over-represented in UEA1+ TEC population, and HeyL only modestly 
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so. This disagreement may be reconciled by considering the perdurance of the Venus 
reporter, since it reports cells both actively signalling and having recently done so. 
Hes1 and HeyL, two Notch-dependent genes confirmed in Chapter VI, both exhibited 
higher expression at E12.5 and had decreased by E14.5. Taken together, the most 
congruent hypothesis may be that Notch activity is higher in primitive TEPCs that go 
on to become mTECs.  
Among the list of candidate genes examined, Hes6 and Fbxw7, two potential 
negative Notch regulators, are downregulated specifically in early mTECs. The 
significance of this expression pattern is currently unknown, but if these genes 
indeed act as negative Notch modulators, it would suggest mechanisms that enable 
the temporary maintenance of Notch signalling in these early mTECs. Furthermore, 
Ascl1 was identified as a potential marker of emerging mTECs.  
Collectively, these data suggest that Notch signalling is active in TEPCs, and 
possibly persists in early mTECs. In the following chapters, I characterized the 














Chapter IV Effect of Notch disruption on TEC development 
 
To investigate the functions of Notch in early TEC development, I used a 
combination of genetic ablation and pharmacological inhibition to eliminate Notch 
signalling in TECs. The conditional knockout model deletes RBPJκ from cells that 
have expressed Foxn1, hence preventing gene expression changes resulting from 
Notch. On the other hand, treating fetal thymic explants with a γ-secretase inhibitor 
(DAPT) in culture inhibits the intracellular cleavage of Notch receptors and the 
production of NICD. The two complementary approaches target different parts of the 
pathway, allowing the distinction between Notch-dependent and -independent effects 
on TEC differentiation.  
 
4.1 A genetic model for Notch perturbation in TECs  
To study the consequence of losing Notch signalling in developing TECs, a 
conditional knockout model was developed by crossing Foxn1Cre (Gordon et al., 
2007) and RbpjFL/FL (Han et al., 2002) mice (Fig 4.1A). In cells expressing Foxn1, 
exons 6 and 7 of the Rbpj gene, which encode the DNA binding domain of the 
protein, are excised by Cre recombinase. Deletion of Rbpj renders these cells 
unresponsive to Notch activation, since the transcriptional complex including NICD 
can no longer bind DNA. For simplicity, Foxn1Cre; RbpjFL/FL homozygous mutants 
are referred to as ‘conditional knockout’ (cKO) hereafter.  
The silent GFP (sGFP) mouse model is a faithful reporter of Cre activity, in which a 
floxed STOP cassette is excised upon Cre recombination, allowing GFP to be 
expressed and detected (Gilchrist et al., 2003). In mice carrying both Foxn1Cre and 
sGFP alleles, almost 100% E14.5 TECs were GFP+ (Fig 4.1B), hence the Foxn1Cre-
mediated recombination is highly efficient by three days after Foxn1 initiation in 
TECs. In addition, PCR genotyping analysis of FACS sorted cKO TECs from 4-
week postnatal thymi showed that while the deleted band was clearly detectable, the 
floxed band was absent (Fig 4.1C). This suggests that TECs carrying the undeleted 
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allele do not contribute significantly to adult cKO thymic epithelium. Therefore, 
deletion of the Rbpj locus was specific and efficient in the cKO model.  
In addition to TECs, Foxn1 is also expressed in the epidermis. This leads to a 
deleterious skin phenotype in the cKO model that becomes apparent between 
postnatal 4 and 8 weeks (Nicolas et al., 2003). These mice lost hair and showed 
abnormal excessive growth in facial skin.  For this reason, most analyses were 
carried out with mice no older than 8 weeks.  
 
4.2 Phenotype of the Rbpj conditional knockouts 
I quantitatively assessed the TEC phenotype of postnatal day 14 Rbpj cKO mice with 
flow cytometry using the antibody panel in Table 1.2 in Chapter 1. At this stage, the 
percentage of mTECs in cKOs was significantly lower than in controls (Male control 
– 79.7 ± 1.7%, cKO - 67 ± 3.1%; Female: control – 58.2 ± 2.5%, cKO – 43.5 ± 
1.4%) (Fig 4.2A). Inspection of cell number revealed that the difference was due to 
the hypoplasia of mTECs in cKOs rather than cTEC expansion (Fig 4.2B). No 
difference was observed between Cre- and heterozygous thymi. Interestingly, the fold 
reduction of mTEC cellularity in cKOs was more pronounced in males than in 
females, and while both mTEChi and mTEClo cellularity were lower in males, only 
the mTEChi subset was significantly reduced in females (Fig 4.2B).  
No difference was found in the relative proportions of DN, DP and SP thymocyte 
populations (Fig 4.2C), indicating that T cell development was not blocked in cKOs. 
There was also no difference in thymic Tregs and Treg precursor numbers (Fig 
4.2D). Therefore, the phenotype appeared restricted to the epithelial compartment.  
To elucidate the kinetics of the mTEC hypoplasia phenotype, Rbpj cKO thymi were 
analyzed at a variety of developmental ages. The reduction of mTEC numbers was 
observed as early as E14.5 using IHC: two mTEC markers K14 and UEA1 were both 
less abundant in cKO thymic sections compared to controls (Fig 4.3A). The 
proportion of mTECs was also lower in cKOs at E18.5 (Fig 4.3B) and postnatal 2-
week (Fig 4.2A). However, the mTEC proportion had normalized by 8-week (Fig 




Figure 4.1. Validation of the Foxn1Cre; RbpjFL/FL conditional knockout (cKO).  
(A) Schematics of Foxn1Cre, RbpjFL and sGFP alleles. 
(B) E14.5 silent GFP activation by Foxn1Cre. Cre recombination efficiency in 
the EPCAM+ TECs was close to 100%.  
(C) PCR analysis of genomic DNA in FACS sorted 4-week cKO and control 
(Foxn1WT; Rbpj+/FL) TECs. The deleted allele (DEL) was present while the 








Figure 4.2 mTEC hypoplasia in 14-day-old Rbpj cKO.  
(A) Plots show representative flow cytometry analysis of total TECs (male). 
The percentage of mTECs in total EPCAM+ TEC population was quantified. 
N=3 for both male and female statistics.  
(B) Absolute cell count of total TEC and subsets at postnatal 14 days. N=3 
for both male and female statistics. Gating strategy is shown in Appendix: 
‘Gating strategy (adult TEC)’.  
(C) The proportion of double negative (DN), double positive (DP) and single 
positive (SP) thymocyte populations in postnatal 14-day female thymi. DN 
thymocytes were further divided to DN1-4 stages and quantified against total 
DN. N=3 and all comparisons are non-significant. Gating strategy is shown in 
Appendix: ‘Gating strategy (adult thymocytes)’.  
(D) Total number of mature thymic Tregs (CD25+ Foxp3+) and two Treg 
precursor populations (CD25+ Foxp3- and CD25- Foxp3+) in postnatal 14-day 
males. Thymocytes were pre-gated on CD4+ TCRβhi CCR6- population. N=3 
and all comparisons are non-significant. Gating strategy is shown in 









Figure 4.3 Kinetics of the mTEC phenotype in Rbpj cKO.  
(A) E14.5 cKO and control embryos were serially sectioned and mTEC 
markers K14 and UEA1 were examined by IHC. Percentage positive for a 
marker was denoted as area that is above positive threshold divided by total 
thymic area. Scale bar=100μm. N=4 for K14 and N=3 for UEA1.  
(B-D) The proportions of mTECs and cTECs in total TECs for (B) E18.5 (C) 
postnatal 8-week and (D) postnatal 16-week male thymi. It is standard 
practice to use CD205 as a fetal cTEC marker, and LY51 for postnatal 
cTECs. N=3 for cKOs at each age. The 16-week data were collected by Dr. 


















4.3 Notch activity in determining mTEC number is temporally 
restricted  
In order to investigate the phenotype further, I set out to determine whether Notch 
was required constantly, or in a confined time window, for mTEC development.  
As TEC-specific Cre drivers that permit temporal control were not available, or not 
specific enough (Ulyanchenko, unpublished), fetal thymus organ culture (FTOC) was 
adopted in conjunction with a widely used γ-secretase inhibitor DAPT to antagonize 
Notch signalling in TEC development from various ages. For older tissue (E15.5 or 
order), fetal thymi were cultured using an established protocol at the air-liquid 
surface (Hikosaka et al., 2008). In this protocol thymic explants were incubated on 
membrane filters over the FTOC medium (Fig 2.1B). Since younger tissue is smaller 
and more fragile, a separate system was designed where the primordia were 
submerged and grown on a thin layer of matrigel (Fig 2.1A). Based on previous 
findings (Popis, Farley and Blackburn, unpublished) that FGF8 and BMP4 elevated 
Foxn1 expression in cultured E10.5 3rd pharyngeal pouches (3PPs), these growth 
factors were added to the N2B27 medium to make up the ‘TEPC medium’.  
I first validated this culture system. E10.5 3PPs grown in TEPC medium increased 
marginally in size over time and became more three dimensional (Fig 4.4A). 
Between E10.5 and E12.5, TECs upregulate Foxn1, Il-7 and downregulate Tbx1. 
After two days in culture, epithelial cells in the explants expressed similar levels of 
Foxn1, Il-7 and Tbx1 to E12.5 TECs (Fig 4.4B), indicating that the TEC precursors 
underwent some degree of maturation in culture. Moreover, E12.5 thymi cultured 
after 3 days exhibited a higher proportion of UEA1+ mTECs and downregulated 
PLET1 further than E15.5 TECs (Fig 4.4C), suggesting that in this period the culture 
system promotes faster differentiation than in vivo.  
When DAPT was added to the medium, at the highest concentration used in this 
thesis (50μM), there was a slight increase in the number of cells expressing apoptosis 
marker active caspase 3 compared to DMSO control (Fig 4.5A). However, the 
proportion of apoptotic TECs was only 3%, indicating that DAPT toxicity was 
relatively low at the concentrations used here. Moreover, treatment of E12.5 lobes 
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with DAPT led to lower expression of the Notch target Hes1 (Fig 4.5B), establishing 
that the inhibitor was effective in targeting the Notch pathway. 
Compared to DMSO-treated controls, E12.5 thymi cultured in the presence of 20μM 
DAPT displayed medullary hypoplasia similar to fetal Rbpj cKOs (Fig 4.6A). 
Treatment with DAPT at three different concentrations (1μM, 10μM and 20μM) 
shows that the reduction of mTEC proportion is dosage-dependent (Fig 4.6A). 
Furthermore, at 20μM DAPT the significant decrease in cell number was specific to 
mTECs (Fig 4.6A). Consistent with flow cytometry results, I showed using IHC that 
K14+ UEA1+ mTEC clusters were readily detectable in control explant (Fig 4.6B). In 
comparison, mTEC foci in the DAPT treated explants were fewer and smaller, 
though not altogether absent (Fig 4.6B). Together, these data demonstrate that γ-
secretase inhibition on E12.5 thymic explants phenocopied the mTEC deficiency in 
Rbpj cKOs. Since targeting Notch receptor cleavage and gene expression produced 
highly similar results, we can deduce with confidence that the mTEC phenotype is 
due to the loss of Notch activity.   
To address whether the requirement for Notch in mTEC development was limited to 
a time window, E14.5 and E16.5 thymi were subjected to DAPT treatment in FTOC. 
For E14.5 primordia DAPT was applied at 10μM and 20μM, and for E16.5 the 
concentration was at 20μM and 50μM. Whereas the mTECs of E14.5 explants were 
also sensitive to DAPT treatment (20μM data shown), mTECs were not diminished 
by DAPT treatment in E16.5 explants, even at 50μM (Fig 4.6C). Taken together, 
these data indicate that Notch is required in a restricted time window to determine 
mTEC cellularity in thymus organogenesis.   
Notably, the E16.5 tissue was cultured at air-liquid interface, which may have 
undermined exposure to the inhibitor as opposed to E12.5 and E14.5 lobes that were 
submerged in culture medium. However, since DAPT did have an effect on the 
mTEC population of E15.5 thymi cultured at medium surface (Chapter VI), which 
are of a similar size, this lack of response possibly reflects more of the properties of 











Figure 4.4 Validation of the TEPC culture condition  
(A) The morphology of a freshly dissected E10.5 third pharyngeal pouch 
(3PP), and 3PP explants after 5-day culture in the TEPC medium. Images 
not to scale. 
(B) The mRNA expression levels of Foxn1, Tbx1 and Il-7 in EPCAM+ TECs 
sorted from E10.5 3PPs cultured in TEPC medium for two days, compared 
with E12.5 TECs. N=2.  
(C) The distribution of UEA1, CD205 and PLET1 in E12.5 thymic lobes 











Figure 4.5 Validation of the γ-secretase inhibitor DAPT  
(A) Apoptosis rate (caspase3 positive) among TECs following overnight 
culture of E12.5 lobes with DMSO or 50μM DAPT.  
(B) Notch target Hes1 was less highly expressed in PLET1+ and PLET1- 
TECs from E12.5 lobes treated with 50μM DAPT for two days compared to 













Figure 4.6 DAPT treatment phenocopies mTEC reduction in Rbpj cKO 
(A) E12.5 thymic lobes were cultured for three days in DMSO control or 
several DAPT concentrations. N=3. Representative plots for total TECs are 
shown. The reduction in mTEC percentage is dependent on the 
concentration of the inhibitor, and the only significant difference in cell 
number was found in the mTECs. Cell number is the total of 9 explants.  
Gating strategy is shown in Appendix: ‘Gating strategy (FTOC)’.  
(B) Immunofluorescence staining of mTEC (K14 and UEA1) and cTEC 
(CD205) markers post culture. Scale bar=100μm.  
(C) The percentage of mTECs following three-day FTOC of the age 
indicated. Data shown are from DMSO controls and the highest 
concentration of DAPT used, namely 20μM for E12.5 and E14.5, 50μM for 
















4.4 Notch is required for the initial emergence of mTECs 
The results so far point to a role of Notch in the early stage of mTEC differentiation. 
Paradoxically, although mTECs were less numerous in the Rbpj cKO model, they 
nonetheless developed and matured. The exact time frame during which the mTEC 
lineage is specified from bipotent progenitors remains controversial (Hamazaki et al., 
2016), and the deletion of Rbpj with Foxn1Cre may commence too late to affect the 
specification of the first mTEC progenitors, considering that functional null state is 
only reached with sufficient decay of residual wildtype RBPJ proteins. 
To address whether Notch regulates mTEC specification, E10.5 3PPs were dissected 
and cultured in TEPC medium with or without DAPT for 5 days and examined for 
mTEC development. The E10.5 endoderm of 3PP is a simple epithelium and there 
has been no evidence that these cells have differentiated towards mTEC or cTEC 
fate. Moreover, contrary to the delay in the genetic model, the inhibitor should block 
the signalling immediately in culture. As RANK receptor signalling is known to 
enhance the proliferation of RANK+ mTEC progenitors present in culture, RANK 
ligand was added to half of the wells treated either with or without DAPT for the last 
two days to enhance any difference between DAPT treatment and control samples 
(Fig 4.7A). 
The control explants generated a small but consistent UEA1+ mTEC population, 
whereas this population was not found after a 5-day culture at 50μM DAPT (Fig 
4.7B). Perhaps due to the presence of parathyroid cells which also originate from the 
3PP, a considerable fraction of EPCAM+ epithelial cells in both conditions expressed 
neither UEA1 nor CD205, therefore I elected to quantify the cell number positive for 
these definitive TEC markers. On average 90 UEA1+ cells per three control explants 
were detected by the end of culture, and this was reduced to less than 20 per three 
explants in tissue treated with DAPT (Fig 4.7B). RANK ligand did not increase the 
mTEC cell count in either condition, suggesting that these mTECs were immature 
progenitors that did not yet express functional RANK receptor. In comparison, the 
number of CD205+ cTECs was not altered by DAPT treatment (Fig 4.7B).  
In line with the flow cytometry data, IHC analysis showed that both K14+ UEA1+ 
mTEC and CD205+ cTEC clusters developed in the control condition, but mTEC 
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development was specifically suppressed by DAPT treatment (Fig 4.7C). In some 
explants, rare cells expressing mTEC markers were found at the border of what 
appeared to be the incompletely closed lumen of the 3PP (arrow), reminiscent of the 
CLDN3/4+ cells in the apical side of 3PP that were speculated to be biased towards 
the mTEC fate (Hamazaki et al., 2007).  
Haematopoietic cells have not entered the thymic anlage at E10.5 (Luis et al., 2016), 
and as a result this culture system was devoid of crosstalk between TECs and T cells. 
Perhaps for this reason the explants did not grow substantially in size, but initial 
differentiation into mTEC and cTEC lineages occurred nonetheless. This observation 
is consistent with previous findings that the initial divergence of cTEC and mTEC 
sub-lineages is crosstalk-independent (Klug et al., 2002; Nowell et al., 2011). Thus, 
the tendency to differentiate may be inherent to TEPCs and does not require 






















Figure 4.7 mTEC emergence is blocked by early Notch inhibition.  
(A) Experimental plan of DAPT culture with E10.5 3PP tissue.  
(B) Representative mTEC:cTEC plots of explants treated with DMSO and 
50μM DAPT throughout are shown. The number of cells (total of three 
explants) in the ‘mTECs’ and ‘cTECs’ gates were counted and quantified for 
all four conditions. N=3.  
(C) Immunofluorescence of mTEC (K14 and UEA1) and cTEC (CD205) 
markers on sections of the explants after culture. Pan-keratin (PanK) was 




















I have shown here that the primary phenotype of the loss of Notch function in 
developing TECs is the reduction of mTEC cell number. Both genetic ablation of 
Rbpj and chemical inhibition data support this conclusion. In contrast, cTEC or 
thymocyte alterations were not observed following Notch perturbation.  
Aside from the comparison between control and Rbpj cKO, this study also revealed 
differences between male and female TECs (Fig 4.2). Given that the sample size is 
not large (N=3 for each sex), the contribution of variation is difficult to exclude. 
Nonetheless, it does appear that the proportion of mTECs in total TECs is higher in 
males, and that TEC cellularity is larger in female thymi. Also, Rbpj cKO seems to 
induce a higher mTEC cellularity fold change in males (3-fold) than in females (2-
fold). 4OH-tamoxifen, a well characterized small molecule targeting the estrogen 
receptor, can increase mTEC proportion in FTOC (personal observation). It is hence 
possible that the sex differences may reflect the role of sex steroid signalling in 
mTEC development. Alternatively, it could be the result of different TEC 
proliferation rate in males and females (Dumont-Lagacé et al., 2014).  
Using the FTOC system, the results presented here also underline that Notch acts in a 
limited time window (E10.5-16.5) to regulate mTEC development, and that Notch is 
required for the emergence of the very early mTEC progenitors. That DAPT 
treatment on later thymi, or what I regard as late Rbpj deletion (by Foxn1Cre), 
incompletely abolished the mTEC population suggests that once the mTEC 
progenitor pool is established, these cells are no longer sensitive to the intensity of 
Notch signalling they experience.  
Indeed, this shift in TEPC behaviour with age is well documented. For instance, fetal 
mTEPCs identified by Sekai and co exhibit very little reconstitution capacity in 
adults (Sekai et al., 2014), suggesting that either they no longer express the same 
markers, or that they are not as regenerative as their fetal counterparts. β5t-
expressing fetal TECs can give rise to both mTECs and cTECs, but this behaviour is 
extinguished postnatally (Ohigashi et al., 2015). Moreover, while all fetal TECs 
actively proliferate, numerous postnatal TECs only cycle slowly (Dumont-Lagacé et 
al., 2014; Tan and Nusse, 2017).  
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In the context of Notch signalling, these results are not in apparent agreement with 
Goldfarb’s conclusion that Notch needs to be suppressed by HDAC3 for mTEC 
differentiation to proceed normally (Goldfarb et al., 2016). However, upon closer 
examination, the two studies can be reconciled by considering the stage-specific 
nature of Notch signalling. Goldfarb et al uncovered the suppression of Notch by 
analyzing a Notch reporter and the Notch gain-of-function mutant in postnatal and 
adult TECs, and by these stages the initial wave of Notch activity in mTEC lineage 
emergence would have already subsided. As is discussed in the next chapter, the 
adult Notch gain-of-function phenotype may be the product of multiple alterations. 
The lack of investigation on the initial fetal phenotype may have led to their different 
and incomplete interpretation.   
The Rbpj cKO mice exhibited a period of mTEC normalization between postnatal 2-
week and 8-week, before a secondary loss of mTEC number was observed by 16-
week. This postnatal kinetics may be explained by the compensatory proliferation of 
mTECs in cKO thymi that eventually led to mTEC progenitor exhaustion. Further 














Chapter V Constitutive Notch activity delays TEC maturation 
 
In the preceding chapter I have shown that the development of the mTEC sub-lineage 
is impaired in the Notch loss-of-function models. Lessons from other organ systems 
emphasize that the dosage of Notch a progenitor cell experience may profoundly 
affect its differentiation outcome (section 1.6). To this end, a gain-of-function 
approach was adopted to study the effect of sustained high Notch activity on TEC 
differentiation. By driving the expression of NICD in developing TECs, the main 
aim of these experiments is to understand whether Notch is instructive or permissive 
for mTEC commitment. 
 
5.1 TEC-specific Notch gain-of-function model 
The results presented in chapter IV suggested that mTEC specification is defective 
when Notch signalling is disrupted in early fetal TECs. This prompted us to study the 
effects of constitutive Notch signalling on TEC differentiation. The Rosa26loxP-STOP-
loxP-NICD-IRES-EGFP model (NICD hereafter) is a Cre-inducible genetic system designed 
to express NICD from the constitutive promoter of Rosa26 gene (Murtaugh et al., 
2003). Cre mediates the recombination and removal of a loxP-flanked STOP 
cassette, allowing the transcription of Notch intracellular domain coding sequence 
and that of EGFP (Fig 5.1A). In order to create a model in which NICD would be 
activated solely in embryonic TECs, homozygous NICD females were crossed to 
homozygous Foxn1Cre male mice. The embryos of this mating scheme would harbour 
one allele of Foxn1Cre and Rosa26NICD each.  
The phenotype of postnatal Foxn1Cre; NICD thymus was described recently 
(Goldfarb et al., 2016). However, these thymi exhibited severe hypoplasia, 
complicating the interpretation of experimental results. Since the γ-secretase 
inhibitor data presented in section 4.3 point to a temporally restricted role for Notch 
in fetal mTECs, TECs were isolated from Foxn1Cre; NICD embryos at E14.5 and 
E16.5 for phenotypic profiling.  
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The NICD construct allows the recombination efficiency to be reported by GFP 
fluorescence of the cells. 90.6 ± 1.3% of the EPCAM+ TECs in Foxn1Cre; NICD 
thymi were GFP+ at E14.5, and the percentage did not increase significantly at E16.5 
(Fig 5.1B). The mosaicism between the GFP+ and GFP- TECs described below (Fig 
5.2B) suggests that GFP accurately reported NICD levels.  
 
5.2 E14.5 NICD phenotype 
Fetal TEC maturation is marked by the gradual downregulation of PLET1 and the 
increase of MHCII in both the mTEC and cTEC lineages (Nowell et al., 2011). 
Strikingly, at E14.5, most if not all Foxn1Cre; NICD TECs were PLET1+ (94.6 ± 
2.9%), whereas 32 ± 4.0% of control TEC were below the positive threshold (Fig 
5.2A Left). Moreover, nearly half of control TECs were MHCII+ (44.7 ± 4.4%) 
compared to 20% of Foxn1Cre; NICD TECs (20.0 ± 1.2%; Fig 5.2A Middle). These 
expression profiles suggest that constitutive NICD reduced the progress of TEC 
differentiation.  
At E14.5 UEA1+ mTECs form a small population, comprising about 5% of total 
TECs. If Notch actively promotes commitment to mTEC fate, the expected outcome 
of NICD overexpression would be the conversion of the majority of TECs to 
mTECs. However, at E14.5 the proportion of UEA1+ mTECs in the Foxn1Cre; NICD 
TECs was not significantly different from that of controls (NICD: 4.9 ± 0.2%; 
controls: 4.4 ± 0.3%; Fig 5.2A Right). Therefore, it seems that forced NICD 
expression initially blocked TEPC differentiation, rather than instructed the 
acquisition of mTEC fate.  
Despite limited cell number, I also analyzed the GFP- TECs in Foxn1Cre; NICD 
thymi. This revealed remarkably lower expression of PLET1 in GFP- compared to 
GFP+ TECs in the same embryos (Fig 5.2B). Indeed, the PLET1 profile of GFP- 
TECs resembled that of control TECs, consistent with their having experienced only 
wildtype levels of NICD. This observation also indicated that the failure to 





Figure 5.1 Cre-inducible Notch gain-of-function model.  
(A) Schematics of the Rosa26 locus before and after excision of the STOP 
cassette triggered by Cre. Adapted from Murtaugh et al, 2003.  
(B) Percentage of recombined cells in total EPCAM+ TECs, indicated by the 











Figure 5.2 Inducible NICD results in TEC maturation arrest but no significant 
conversion to mTECs.   
(A) The percentage of cells expressing PLET1, MHCII and UEA1 in total 
EPCAM+ TECs. N=3 for control and N=4 for NICD. UEA1+ population was 
further divided into UEA1lo and UEA1hi subsets in the plots. Total UEA1+ was 
used for statistical analysis. 
(B) PLET1 expression mosaicism in the GFP+ and GFP- populations of E14.5 
NICD TECs.  



















5.3 E16.5 NICD phenotype 
As E14.5 TECs undergo further proliferation and differentiation, it was of interest to 
analyze control and Foxn1Cre; NICD thymi at a later stage. E16.5 fetal tissue was first 
studied with IHC for the expression of various TEC markers (introduced in Table 1.3 
in Chapter 1).  
Early TEC progenitors are mostly K5+ K8+, and as differentiation proceeds K5 is 
confined to the medullary region and the CMJ (Klug et al., 2002; Klug et al., 1998). 
The demarcation between K5+ and K5- areas was lost in Foxn1Cre; NICD thymi and 
K5+ K8+ co-expression was detected throughout the thymic section (Fig 5.3A). The 
disruption of the cortico-medullary architecture was also illustrated by the expression 
pattern of another mTEC marker K14. Instead of the distinctive medulla (K14+ 
CD205-) and cortex (K14- CD205+) seen in the control thymi, constitutive NICD led 
to the extension of K14 expression into the CD205+ presumptive cortical domain 
(Fig 5.3B). Interestingly, unlike the altered pattern of medulla-associated keratins, 
the border between UEA1+ and UEA1- regions in Foxn1Cre; NICD thymi 
corresponded in precisely converse fashion with CD205. Despite the aberrant 
expression of K5 and K14, AIRE protein expression within the UEA1+ regions was 
at comparable levels in Foxn1Cre; NICD (32.5% of UEA1+ cells) and control tissue 
(32.9% of UEA1+ cells) (Fig 5.3C), suggesting that mTEC precursors specified 
under high Notch activity are competent to respond to the activators upstream of 
AIRE. The expression of PLET1 is also broader in Foxn1Cre; NICD thymi (0.225 per 
thousand μm2 in control; 0.859 per thousand μm2 in NICD) (Fig 5.3C).  
Similar to the IHC data, flow cytometry revealed that control TECs could be 
separated into distinct UEA1+ CD205- mTECs and UEA1- CD205+ cTECs. However, 
a substantial proportion of TECs expressed intermediate levels of both markers in the 
Notch gain-of-function model (Fig 5.4 Left). Notwithstanding the poor separation, 
the percentage of UEA1+ CD205- TECs in Foxn1Cre; NICD thymi was 35.7 ± 7.6%, a 
5-fold increase from 6.6 ± 1.1% in controls, and overall the epithelium expressed 
higher levels of PLET1 (NICD: 76.3 ± 10.3%; controls: 22.7 ± 5.8%; Fig 5.4 
Middle), as was the case for E14.5 samples. Taken together with the E14.5 data, 
these data suggest that although constitutive Notch activity does not convert all TEC 
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progenitors into mTECs, the delayed differentiation evident at E14.5 may contribute 
to a latent increase in the propensity for mTEC differentiation and/or proliferation. 
Examined separately, both UEA1+ CD205- and UEA1- CD205+ populations in 
Foxn1Cre; NICD embryos exhibited lower MHCII and higher PLET1 expression than 
those in the age-matched wildtype controls (Fig 5.5), indicative of more primitive 
differentiation states. However, given that the proportional difference in MHCII 
expression in mTECs was fairly small (control: 90.4 ± 3.1% positive; NICD: 76.9 ± 
4.8% positive) (Fig 5.5A), and that Foxn1Cre; NICD mTEC expressed AIRE 
normally (Figure 5.3C), these mTECs were arguably similar in differentiation status 
to their wildtype counterparts. On the contrary, the proportion of MHCII+ TECs 
among the CD205+ subset was reduced almost by half (control: 79.2 ± 5.9%; NICD: 
48.2 ± 5.3%), suggesting the block in cTEC maturation imposed by NICD was 
considerably stronger (Fig 5.5B). Since CD205 is expressed by early bipotent TEPCs 
and cTECs alike (Baik et al., 2013), this phenotype may again demonstrate that the 







Figure 5.3 IHC profiles of (A) K5, K8 and UEA1 (B) K14, CD205 and UEA1 






Figure 5.4 E16.5 NICD TECs exhibit poor resolution between mTEC and 
cTEC populations, high mTEC proportion, and PLET1hi profile.  
Left: total TECs were divided based on the expression of mTEC marker 
UEA1 and cTEC/TEPC marker CD205.  
Middle: the PLET1 profile of total E16.5 TECs.  





Figure 5.5 Developmental arrest in both sub-lineages of E16.5 NICD TECs. 
PLET1 and MHCII expression (A) UEA1+ CD205- mTECs and (B) CD205+ 
UEA1- cTEC/TEPCs in E16.5 thymi. The UEA1+ and CD205+ TECs were 




5.4 Discussion  
The Rbpj cKO and γ-secretase FTOC data supported the hypothesis that Notch 
signalling acts in a limited time window (E10.5-16.5) to determine the pool size of 
mTEC progenitors, at least partly via regulating mTEC specification. It was 
imperative to elucidate whether Notch activity is sufficient to induce mTEC cell fate 
or is merely necessary for it. The characterization of Notch gain-of-function model 
provided essential data that allow us to distinguish between the two possible 
mechanisms.   
The two scenarios are depicted in Figure 5.6. In hypothesis A, which I term the 
‘mTEC commitment model’, Notch directly drives the cell fate decision of bipotent 
TEPCs into the mTEC lineage. In the absence of Notch, mTEC commitment does not 
occur whereas the cTEC lineage is unaffected. For this model to be correct, we 
would predict that higher Notch activity will favour mTEC fate, and the constitutive 
expression of NICD will convert a higher percentage of TECs into the mTEC 
lineage. Since this model only concerns cell lineage, we would not expect to see 
alterations in the subsequent maturation of mTECs and cTECs.   
On the other hand, hypothesis B (mTEC competence model) posits that Notch 
regulates TEC differentiation by maintaining the bipotency of TEPCs. This scenario 
takes into account the theory that cTEC/mTEC lineage specification is asymmetric, 
as TEPCs resemble cTECs in terms of function and phenotype while mTEC 
commitment likely requires an additional stimulus (reviewed in Alves et al., 2014). 
Consequently, mTECs cannot emerge when TEPC bipotency (mTEC competence) is 
prematurely extinguished in the Notch loss-of-function condition. If this model is 
correct, we would predict that constitutive Notch activity would arrest TECs at a 
TEPC-like state, and maturation is completely blocked.  
The results presented here show that the primary effect of the constitutive expression 
of NICD was the retention of immature TEC markers, although an increased mTEC 
contribution was observed at a later stage. Importantly, even at the later time point 
(E16.5), the effect of NICD induction was not simply numerical, as both mTEC and 
cTEC/TEPC populations displayed a primitive marker expression profile. These 
observations are more consistent with the mTEC competence model than the mTEC 
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commitment model, but this simple either/or model fails to explain why some degree 
of TEC differentiation did occur, and additional factors need to be considered.  
It is possible that the latent pro-mTEC effect observed at E16.5 resulted from 
secondary mechanisms that modulated Notch activity above the extent of NICD 
induction. This could potentially account for different outcomes being favoured by 
the graded response to Notch. For instance, if mTEC commitment requires a higher 
threshold than the maintenance of bipotent TEPCs, such a threshold may be achieved 
through positive feedback. The alternative theory is that mTEC fate is instructed by a 
yet unidentified signal, and since the TEPC pool is larger in the presence of NICD 
due to impaired differentiation to the cTEC lineage, more cells would in turn be 
competent to be instructed into the mTEC lineage.  
The dosage of NICD induction is important in the context of this experiment. 
Following Cre-mediated recombination, one allele of the Rosa26 locus drives the 
expression of NICD. Hence the result is similar to homogeneous Notch activation at 
physiological levels in all recombined cells. If indeed the gain-of-function phenotype 
is dosage sensitive, similar to the loss-of-function phenotype (Fig 4.6A), we may 
expect to observe a more severe differentiation arrest upon the induction of multiple 
copies of NICD.  
Of interest, manipulating Foxn1 expression, either by generating hypomorphic alleles 
(Nowell et al., 2011) or activating the Foxn1 repressor TBX1 (Reeh et al., 2014), 
resulted in the primitive TEC phenotype similar to forced NICD expression – high 
PLET1 and low MHCII. The reason that NICD-expressing TECs did undergo some 
degree of differentiation may be that FOXN1 remained switched on and countered 
the effect of excessive Notch. The relationship between Notch and Foxn1 is further 








Figure 5.6 Two models for the Notch loss-of-function phenotype. 
(A) Notch regulates the commitment of bipotent TEPCs to the mTEC lineage.  
(B) Notch regulates the maintenance of bipotent TEPCs (i.e. the competence 
to become mTECs). In the absence of Notch TEPCs prematurely differentiate 
into cTECs.   
The size of circles indicates cell number. The width of arrows represents the 
probability of the event to occur.  
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Chapter VI Mechanistic insights of Notch signalling in TECs 
 
Having investigated the role of Notch in TEC development by studying loss- and 
gain-of-function mutants, and demonstrated a profound effect on mTEC 
development, I wish to determine how Notch pathway controls this process. Two 
candidate targets, RANK signalling (section 1.4.7) and ASCL1, were examined. To 
identify novel targets, RNA-seq was also carried out to discover transcriptional 
changes brought about by altering Notch activity.  
 
6.1 Potential synergy between Notch and RANK signalling  
Several tumour necrosis factor superfamily (TNFSF) ligands are secreted by 
thymocytes and serve as agents in thymic crosstalk to enhance the proliferation and 
maturation of mTECs, partly through activating the canonical and non-canonical 
NFκB pathways. Of these factors, RANK ligand (RANKL) uniquely induces both 
the expansion of mTECs and the acquisition of AIRE expression (Bichele et al., 
2016; Hikosaka et al., 2008). To study the potential interaction between Notch and 
NFκB pathways, the FTOC protocol in which E15.5 lobes are cultured at air-liquid 
interface over medium containing deoxyguanosine (dGuo) and RANKL was 
adopted. The purpose of dGuo treatment was to deplete T cells and thus to block 
intrinsic crosstalk between thymocytes and TECs. Simultaneously, the provision of 
RANKL readily facilitated the increase in mTEC frequency and in this regard 
compensated the lack of T cells (Fig 6.1A), concordant with published reports.  
I first addressed whether inhibiting Notch signalling would abolish the effect of 
RANK stimulation. To this end, three separate culture conditions were established. 
All three conditions contained dGuo, the first dGuo alone, the second supplemented 
with RANKL, and the third with both RANKL and DAPT to impose Notch 
signalling inhibition. After three days, low DAPT concentration had no impact on 
RANK stimulation, however at 50μM an effect was observed. The co-treatment of 
RANKL and DAPT elicited increased mTEC frequency from baseline dGuo levels, 
but the rise was attenuated compared to RANKL treatment alone (Fig 6.1).  
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Since DAPT toxicity is minor at the concentration used here (Fig 4.5A), the apparent 
synergy between Notch and RANK in driving mTEC development may have arisen 
via two possible mechanisms. Notch may directly interact with components of the 
pathway activated by RANKL, and hence DAPT treatment may have reduced the 
efficiency of RANK signalling. Alternatively, Notch and RANK may regulate 
separate checkpoints in the mTEC lineage without physical crosstalk. In such a 
scenario, Notch inhibition does not hamper the efficiency of RANK stimulation, but 
rather constrains the number of cells capable of responding to RANKL. To 
distinguish between these two hypotheses, E15.5 thymi from Rbpj cKO and control 
littermates were interrogated using the same FTOC set-up. Since the genotype of 
embryos was unknown at the start of culture, half of the embryos were incubated in 
the dGuo only condition, and half in dGuo with RANKL.  
In terms of mTEC frequency, the influence of the two pathways appeared to be 
additive. Control explants treated with RANKL yielded the highest proportion of 
mTECs, whereas Rbpj cKO thymi cultured without RANK signalling input 
contained a barely detectable mTEC population (Fig 6.2A). The absence of either 
Notch (through Rbpj deletion) or RANK signalling (through dGuo treatment and the 
lack of RANKL) decreased the mTEC frequency to a similar level, and there were 
significantly more mTECs in the cKO tissue co-treated with RANKL than cKO lobes 
in dGuo alone (Figure 6.2A, B). Thus, mTECs residing in the Rbpj cKO thymi could 
respond to RANKL.   
Furthermore, in control explants, RANKL also raised the proportion of MHCII+ 
mTECs (Fig 6.2C), of which AIRE+ mTECs are a subset. Notably, RANK-stimulated 
mTECs in cKO explants showed a similar percentage of MHCII+ cells to RANK-
stimulated controls, and significantly higher than the few mTECs in unstimulated 
cKO tissue (Figure 6.2C). This finding suggests that the efficiency of RANK 
treatment was comparable in control and Rbpj cKO explants. In contrast, explants 
cultured in all four conditions contained similar proportions of MHCII+ cTECs 
(Figure 6.2D), an expected finding as RANKL does not act on cTECs. Overall, these 
results, and the 3PP culture experiments in Chapter IV, illustrated that Notch and 
RANK regulate distinct events in mTEC development. Although the timing of the 
two checkpoints seems to overlap, placing Notch temporally upstream of RANK, the 
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functional data do not necessarily require direct genetic or biochemical interactions 
between those pathways for explanation.  
 
6.2 Notch does not facilitate mTEC development through ASCL1 
The bHLH transcription factor ASCL1 is preferentially expressed in adult mTECs 
over cTECs (Goldfarb et al., 2016). In development, the appearance of Ascl1 mRNA 
expression was found to correlate with the emergence of mTECs in the fetal thymus 
(Fig 6.3A). Moreover, its expression in E14.5 Rbpj cKO TECs was reduced by 3-
fold in both PLET1+ and PLET1- populations compared to control (Fig 6.3B). These 
results led me to speculate that Ascl1 may be a factor downstream of Notch in TEC 
differentiation. Alternatively, it may simply be a marker of early mTECs.  
To address this issue, mice heterozygous for an Ascl1 null allele were crossed to 
generate homozygous Ascl1-/- null mutants (Guillemot et al., 1993). Thymi were 
dissected from E17.5 fetuses, cryo-sectioned and analyzed with IHC. No differences 
were detected with regard to the expression of mTEC markers K14, CLDN3 and 
UEA1, or cTEC marker CD205 between wildtype and Ascl1 null thymi (Figure 
6.3C). Therefore, the significance of ASCL1 appears not to be in the establishment 
of the mTEC lineage. The reduced Ascl1 expression in Rbpj cKO was likely due to 











Figure 6.1 Notch inhibition by DAPT attenuated mTEC expansion elicited by 
RANK ligand treatment.  
Wildtype E15.5 thymic lobes were dissected and cultured for three days.  
(A) The proportions of UEA1+ mTECs and CD205+ cTECs in total TECs after 
culture.  










Figure 6.2 The effect of RANK ligand treatment on E15.5 control and Rbpj 
cKO thymi. Thymi lobes from Rbpj cKO and control littermates were cultured 
for three days in individual 24-well plate wells.  
(A) The proportions of UEA1+ mTECs and CD205+ cTECs in total TECs after 
culture. The four samples presented were of the same litter.  
(B-D) Quantitation of (B) the mTEC frequencies in total TECs, (C) proportions 
of MHCII+ cells in mTECs, and (D) proportions of MHCII+ cells in cTECs after 
culture.  
N=6 for dGuo only controls. N=5 for dGuo only cKO thymi. N=5 for RANKL 
treated controls. N=4 for RANKL treated cKO thymi. 












Figure 6.3 ASCL1 does not account for the function of Notch in TEC 
development.  
(A) The expression of Ascl1 mRNA in early TEC populations. N=6 for E12.5 
and E13.5 populations, and N=3 for E14.5 populations.  
(B) Ascl1 mRNA expression in the PLET1+ and PLET1- E14.5 TEC 
populations of Rbpj cKO (‘KO’) and control littermate thymi (‘Ctrl’). 200 cells 
per embryo were isolated and N=7.  
(C) IHC analysis of mTEC and cTEC markers on E17.5 Ascl1-/- null mutant 



















6.3 Positive autoregulation of the Notch pathway 
To shed light on how Notch signalling controls TEC cell fate, I studied the 
transcriptomes of Rbpj cKO and Foxn1Cre; NICD fetal TECs. As mTEC number is 
influenced by Notch, I reasoned that epithelial cells in early primordia should be 
subdivided according to PLET1 expression, which is less sensitive to Rbpj deletion, 
rather than mTEC and cTEC markers. The proportion of mTECs expressing PLET1 
is higher than cTEC/TEPCs throughout fetal thymic organogenesis (Sheridan, 
unpublished), therefore in control samples a slight mTEC enrichment can be 
expected in the PLET1+ subset.  
To validate this approach, RT-qPCR was performed on FACS-sorted E14.5 control 
and Rbpj cKO TECs in order to assess the expression of Notch pathway genes and 
canonical targets. This set of expression patterns (Fig. 6.4) provided several insights. 
Firstly, as expected, the levels of conventional Notch targets Hes1 and Heyl were 
reduced in cKO PLET1+ and PLET1- TECs (Fig 6.4E, F). Secondly, as opposed to 
Hes1 and Heyl whose expression was similar in the PLET1+ and PLET1- 
populations, the levels of Notch1, Notch3 and Jag1 in controls were higher in the 
PLET1+ compartment (Fig 6.4A, C, D). Considering their enrichment in E14.5 
mTECs (Chapter III), these results reinforced the notion that PLET1+ population 
contains more mTECs. Next, the expression of Notch1, Notch2, Notch3 and Jag1 in 
both populations was significantly lower in cKO thymi compared to controls (Fig 
6.4A-D), suggesting that one outcome of Notch activation seems to be the 
upregulation of Notch receptors and JAG1 ligand. One can envisage that this positive 
feedback loop may lead to sharpened responsiveness to further Notch signalling, and 
in the case of JAG1, lateral propagation to extend the domain of cells experiencing 
Notch. Finally, the expression of Foxn1 was unchanged in Rbpj cKOs (Fig 6.4G), 
ruling out the possibility that Notch is a major regulator of Foxn1 at this stage. 
To conduct a more unbiased transcriptomic analysis, I then collected TECs for RNA 
sequencing. To this end, 100 cells were collected for each of the following 
populations: E12.5 PLET1+ total TECs from control and cKO rudiments; E14.5 
PLET1+ and PLET1- TECs from control and cKO thymi; E14.5 constitutive NICD 
PLET1+ TECs. NICD TECs at E14.5 were nearly completely PLET1+ (Figure 5.2A), 
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therefore only this population was collected. Bioinformatics analysis was performed 
by Anastasia Kousa, and the results were interpreted by Anastasia Kousa and me.  
Principal component analysis (PCA) using the 500 most differentially expressed 
genes in all datasets revealed that the transcriptomes broadly separated into three 
groups on the two most influential components (Fig. 6.5A). The E14.5 Foxn1Cre; 
NICD gain-of-function samples formed a tightly clustered group (Group 1). 
Although of the same biological age, E14.5 control and Rbpj cKO samples clustered 
together (Group 2) at some distance from the NICD TECs. Moreover, a third group 
(Group 3) was found to consist of E12.5 control and cKO samples. Varying the 
number of genes used to plot PCA had little effect on the overall cluster composition. 
If we consider the linear route on the PCA plot between Group 3 and Group 2 to be 
developmental progression, it may be argued that persistent NICD delayed TEC 
maturation. However, Group 1 also deviated substantially from this linear axis, 
indicating a cell state not present in normal development, or the expansion of a rare 
cell population in the gain-of-function samples.  
The transcriptomes of E12.5 Rbpj cKO and E12.5 control TECs were highly similar, 
possibly due to the insufficient decay of residual wildtype RBPJ proteins. In 
comparison, when all E14.5 control and cKO TECs (Group 2 of Fig. 6.5A) were 
plotted separately, the control PLET1+ and PLET1- populations, representing mTEC 
and cTEC enriched subsets respectively, were distinguishable on PC2, whereas such 
distinction was much smaller between the corresponding cKO subsets (Fig 6.5B). 
Overall, these data highlight that the deletion of Rbpj begins to exert transcriptional 
changes between E12.5 and E14.5.  
To identify genes and pathways regulated by Notch, a Gene Set Enrichment Analysis 
(GSEA) was carried out comparing the transcriptomes of E14.5 PLET1+ NICD 
against E14.5 PLET1+ controls. 35 pathways were found to be statistically 
upregulated, and 2 downregulated, in NICD samples. Only three of these 
substantially altered pathways, all of which were upregulated, concern cell signalling 
(Table 6.1).  
Consistent with the positive autoregulation shown by RT-qPCR comparing loss-of-
function to control TECs (Fig 6.4), a strong Notch pathway signature was found in 
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the NICD transcriptome under ‘Notch1ICD regulates transcription’ (Table 6.2A). 
Beside the conventional bHLH targets and Notch1, two Mastermind-like genes, 
Maml2 and Maml3, were also found to be elevated. MAML factors form the 
transcriptional complex with RBPJ and NICD to promote Notch-dependent gene 
expression (Petcherski and Kimble, 2000; Wu et al., 2002). By producing more 
MAML2 and MAML3, it is plausible that TECs may become more efficient in 
transducing the signal and more readily responsive to Notch activation. 
Notch aside, two more gene sets of interest were uncovered by the analysis. Despite 
including only four significantly upregulated genes, the list ‘Inflammatory response 
pathway’ contains some of the most highly induced genes in the entire dataset (Table 
6.2B). The top three genes identified encode collagen molecules Col3a1, Col1a1 and 
Col1a2. The role of collagen on TEC differentiation is not clear but the remodelling 
of extracellular matrix (ECM) may be a mechanism through which Notch maintains 
the potency of TEPC. As an example, muscle satellite cell quiescence requires Notch 
signalling and the integrity of the basal lamina (Mourikis and Tajbakhsh, 2014). 
Many ECM proteins (integrins, collagens and other adhesion molecules) are Notch 
targets in satellite cells (Brohl et al., 2012), hinting at a role of the pathway to aid the 
construction of stem cell niche.  
We have also found increased expression of genes ascribed to EGFR signalling 
under ‘Signalling by constitutively active EGFR’ (Table 6.2C). Apart from Egfr 
itself, several genes coding for cytoplasmic components of the pathway such as Kras, 
Pik3ca and Pik3r1 were identified. The EGFR-STAT3 axis has been shown to 
regulate mTEC cellularity (Satoh et al., 2016), raising the possibility that Notch 














Figure 6.4 Candidate genes downregulated in Rbpj cKO TECs.  
200 PLET1+ and PLET1- TECs per E14.5 Rbpj cKO and control littermate 
thymi were sorted, and their mRNA examined by RT-qPCR. Two tailed T test 
was conducted for both populations between controls and cKOs.  














Figure 6.5 Principal component analysis (PCA) of RNA-seq datasets, by 
Anastasia Kousa.  
(A) PCA with top 500 differentially expressed genes in all samples.  
Group 1: E14.5 NICD (gain-of-function, ‘GOF’).  
Group 2: E14.5 control (‘WT’) and Rbpj cKO (loss-of-function, ‘LOF’). Colour 
code labels: Top left – control, PLET1+; Top right – cKO, PLET1+; Bottom left 
– control, PLET1-; Bottom right – cKO, PLET1-.   
Group 3: E12.5 control and Rbpj cKO. Colour code labels: Left – control; 
Right – cKO.  
(B) PCA of E14.5 control (‘WT’) and Rbpj cKO (‘LOF’) only. Plotted with top 



































18 0.43 1.39 0.054 0.232 0.959 
 
Table 6.1 Statistically upregulated signalling pathways in transgenic NICD 
E14.5 PLET1+ TECs compared to control E14.5 PLET1+ TECs. The genes in 
these lists with significantly enhanced expression are shown in Table 6.2.  









Table 6.2 Significantly upregulated genes that contributed to gene sets in 
Table 6.1, and fold enrichment in E14.5 NICD PLET1+ TECs against E14.5 
control PLET1+ TECs. Note not all genes in the Table 6.1 gene sets (column 
























6.4 Interplay between Notch and FOXN1 
To make sense of how Notch specifically regulates TEC lineage decision and 
potency, a panel of markers was selected to reflect the maturation of TECs as well as 
the differentiation towards either mTEC or cTEC sub-lineage among the RNA-seq 
samples (Fig 6.6). Unsupervised clustering split the samples into three groups in 
agreement with PCA in Fig 6.5A. Interestingly, there was also a sub-cluster in the 
E14.5 control and Rbpj cKO group that included only the PLET1+ controls (W5+, 
W7+ and W17+), indicating a similar pattern to that revealed in Fig 6.5B. As for 
gene clusters, three broad groups were separated, of which the second one could be 
further divided based on the overall pattern (purple and cyan).  
Here I attempt to summarize the patterns of the four gene clusters (in top-down order 
in Fig 6.6). The green cluster genes were expressed at variable levels at E12.5, and at 
E14.5 were more highly expressed in PLET1+ than PLET1- populations. In Foxn1Cre; 
NICD thymi where only PLET1+ population was present, these genes were 
uniformly highly expressed. This cluster includes mTEC associated Krt5 (encodes 
cytokeratin 5), Cldn3, Cldn4 and generic TEC marker Epcam. The pattern of Plet1 
expression verified the purity of samples.   
The purple and cyan genes, collectively forming the second cluster, were uniformly 
upregulated from E12.5 to E14.5 in both control and Rbpj cKO TECs. The purple 
subgroup genes, to which Foxn1 and its targets Dll4, CtsL, Psmb11 (encodes β5t) 
belong (Zuklys et al., 2016), failed to be upregulated in the Foxn1Cre; NICD TECs. 
On the contrary, genes in the cyan subgroup were upregulated relatively normally 
despite constitutive Notch activity. Two classes of genes were found in the cyan 
cohort, either associated with mTEC development (Ltbr, Krt14, Tnfrsf11a [encodes 
RANK] and Cd40), or involved in antigen presentation (Ciita, H2-Aa, H2-Ab1 and 
H2-Eb1). Notably, the relatively normal expression of Ltbr, Rank and Cd40 in loss- 
and gain-of-function datasets illustrates the weak dependence of NFκB signalling on 
Notch, in concordance with functional characterization (section 6.1).  
Finally, the yellow cluster genes were expressed at variable levels in E12.5 and 
E14.5 control and loss-of-function samples, but were uniformly repressed in the 
presence of NICD. Genes in this cluster do not seem to share a clear category. Pax9 
126 
 
is important for TEC development (Hetzer-Egger et al., 2002). Kitl is a Foxn1 target 
and together with Il-7 instructs early thymocyte development in the cortex (Godfrey 
et al., 1992; Morrissey et al., 1994). Fgfr2 has been implicated in the growth of early 
thymic epithelium (Revest et al., 2001). What is more, Ly75 (encodes CD205) is 
expressed both in TEPCs and cTECs. 
Several conclusions can be drawn from this panel. First, while the mTEC program 
(Cldn3, Cldn4, Krt5, Krt14, Ltbr, Rank and Cd40) appears compatible with enforced 
Notch signalling, the expression of cTEC markers (Krt8, Ctsl, Psmb11 and Ly75) 
was severely reduced. Therefore, the effect of ubiquitous Notch activity was 
primarily manifested in the TEPC/cTEC lineage. Secondly, many of the cTEC-
related genes significantly lowered in the NICD datasets were FOXN1 targets, 
suggesting that Notch-induced blockade of cTEC progression may be mediated 
through repressing the expression and/or activity of FOXN1. Thirdly, the yellow 
cluster genes were specifically repressed in the NICD samples. This may have 
contributed to a transcriptomic state that is not normally present during thymic 
organogenesis, reflected in the deviation from the temporal advance in Fig 6.5A.  
We further explored the relationship between Notch and FOXN1 with the 
Rosa26CAG-FL-STOP-FL-Foxn1-IRES-GFP ‘iFoxn1’ transgenic mice, an inducible Foxn1 
overexpression model controlled by Cre (Bredenkamp et al., 2014b). Dr. Kathy 
O’Neill curated these results (Fig 6.7).  
Mating between male Foxn1Cre and female iFoxn1 mice produced double transgenic 
progeny that continuously overexpress Foxn1 in TECs, referred to here as TgFoxn1. 
Very few mTECs were present in E17.5 TgFoxn1 thymi, a strongly similar 
phenotype to the Rbpj cKO Notch loss-of-function model (Fig 6.7A, B). The overall 
number of CD205+ cTECs were not significantly different littermate controls, but a 
substantial proportion of cTECs did not express MHCII (Fig 6.7B). Gene expression 
analysis using RT-qPCR confirmed a threefold increase in Foxn1 expression and a 
twofold reduction in the mTEC expression of Notch1 and Notch3 (Fig 6.7C). Thus, 
the phenotypic similarities between Notch loss-of-function and FOXN1 gain-of-
function appear to be supported by molecular interactions. A possible mechanism is 
that FOXN1 represses Notch through its direct target Fbwx7. FBXW7 is known to 
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promote the turnover rate of NICD (Carrieri and Dale, 2016), limiting Notch target 
gene expression. Future experiments are required to verify this hypothesis.  
To sum up, our RNA-seq and Foxn1 overexpression experiments revealed cross 
repressive interactions between Notch and FOXN1. Based on the functional 
characterization of Notch and published literature on FOXN1 (Nowell et al., 2011), it 
seems plausible that there is a competition between the two factors, with Notch 
favouring the TEPC state and FOXN1 promoting differentiation. It is notable that in 
this model mTEC development is highly connected to the maintenance of TEPCs. As 
remarked in the last chapter, that Notch is instructive in the entry into the mTEC 
lineage is not the only theory compatible with our results. Alternatively, by 
safeguarding the bipotency of TEPCs, the pre-requisite for mTEC commitment, 
Notch may allow the time window for mTEC specification to extend beyond the 





Figure 6.6 Expression of selected lineage markers in all RNA-seq datasets. 
Heatmap courtesy of Anastasia Kousa.  
Clustering of samples is consistent with PCA (Fig 6.5):  
Group 1: E14.5 Foxn1Cre; NICD (‘G’) 
Group 2: E14.5 control (W) and Rbpj cKO (L) 
Group 3: E12.5 control (W) and Rbpj cKO (L).  
Four broad groups (green, purple, cyan and yellow) were produced based on 











Figure 6.7 Foxn1 overexpression phenotype resembles Rbpj cKO.  
(A) Representative plots showing the percentage of UEA1+ mTEC and 
CD205+ cTEC populations in E17.5 control and Foxn1Cre; iFoxn1 (‘TgFoxn1’) 
thymi.  
(B) Absolute cell numbers of mTECs and cTECs in E17.5 control and 
TgFoxn1 thymi, divided by the presence or absence of MHCII marker. Error 
bars show standard deviation. N=3.  
(C) The mRNA expression of Foxn1, Notch1 and Notch3 in mTECs and 
cTECs isolated from control and TgFoxn1 thymi. Relative expression values 


















This chapter addresses the mechanisms through which the Notch pathway may 
regulate the differentiation of TEPCs.  
Since the NFκB pathway is also known to be a potent inducer of mTEC 
development, I first characterized the relationship between Notch and NFκB using 
FTOC. Notch inhibition reduced the extent of mTEC expansion resulting from 
RANK stimulation, indicating that the two pathways are synergistic in generating 
normal mTEC cellularity. Moreover, RANK remains effective in expanding the 
mTEC population even in the absence of RBPJ and hence canonical Notch 
signalling. This suggests that the two pathways are likely to be independent, although 
we cannot categorically rule out the possibility that these mTECs have escaped Rbpj 
deletion by Cre. Nevertheless, taking into account results in preceding chapters 
which show that Notch regulates mTEC emergence by acting at the level of TEPCs, 
and that RANK is only effective in stimulating maturing mTEC precursors (Akiyama 
et al., 2016; Baik et al., 2016), an argument could be made that temporally, rather 
than biochemically, Notch is upstream of RANK. One limitation of this culture 
approach is the simplification of the NFκB pathway down to a single ligand, 
RANKL, given the involvement of other ligands, for instance lymphotoxin (Boehm 
et al., 2003). Further experiments are required to elucidate whether the relationship 
between Notch and RANK also holds for Notch and LTβR.  
To unveil targets and mechanisms underlying the Notch phenotype, RNA-seq was 
conducted to investigate the transcriptomic changes in Notch loss- and gain-of-
function models. We detected no difference between E12.5 control and Rbpj cKO 
transcriptomes, suggesting that the effective Notch loss-of-function is delayed 
compared to Cre initiation, possibly due to the slow degradation of wildtype RBPJ 
proteins. To our surprise, the differences between E14.5 control and Rbpj cKO 
transcriptomes are also modest. This might be partly due to which TEC populations 
were collected. To minimize the effect of defective mTEC development, I chose to 
collect the PLET1+ and PLET1- subsets as the cellularity of these populations is less 
affected by Rbpj cKO. This decision may have contributed to the modest differences 
because only a minority of E14.5 PLET1+ and PLET1- TECs are mTECs, thus the 
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single-cell level changes are diluted by cells whose gene expression is unaffected by 
Notch. The main difference between E14.5 control and Rbpj cKO expression is the 
reduction of Notch pathway genes, including Notch1, Notch3, Jagged1, Hes1 and 
HeyL.  
In comparison, analysis of the Notch gain-of-function transcriptomes revealed more 
profound changes. The induction of NICD raised the expression of Notch pathway 
components and targets in E14.5 TECs, again reinforcing the idea that the pathway 
exhibits positive feedback in early fetal TECs. Cells actively transducing Notch 
signalling may perpetuate the activity through the upregulation of some key targets – 
the receptor Notch1 and transcriptional co-activators Maml2 and Maml3. Moreover, 
we also discovered that some of the most highly upregulated genes in the presence of 
constitutive NICD are collagen genes Col3a1, Col1a1 and Col1a2. Exactly how the 
extracellular matrix influences the development of TEPCs is unclear, but this finding 
provides clues for future tissue engineering attempts aiming to devise optimal 
conditions for controlling TEC differentiation. A third pathway downstream of Notch 
appears to be the EGFR pathway, through which mature mTECs undergo expansion 
(Satoh et al., 2016).  
In line with phenotypic profiling, our RNA-seq data showed that in the Notch gain-
of-function model, the expression of many cTEC enriched genes fails to be 
upregulated at E14.5, and many of these genes are Foxn1 and its targets. This finding 
prompted us to study how Notch influences, and is influenced by, FOXN1, so far 
considered to be unimportant in TEC lineage decision (Nowell et al., 2011). 
Constitutively high expression of FOXN1 led to a reduced mTEC population, 
phenocopying the effect of Notch loss-of-function. Gene expression analysis 
revealed that FOXN1 induction diminished the expression of Notch receptors, 
suggesting a direct link between excessive FOXN1 and the suppression of Notch 
activity.  
As alluded to in Chapter V, TECs in the Notch gain-of-function model display 
similar maturation arrest to cells in FOXN1 hypomorphs. It may be helpful to think 
of both Notch and FOXN1 as TEC maturation or TEPC differentiation factors. With 
Notch antagonizing differentiation and FOXN1 driving maturation, there exists a 
133 
 
state of cross-repressive interaction between the two factors. Since the TEPC 
phenotype appears to be intrinsically linked to mTEC differentiation potential, the 
precocious maturation of TEPCs, caused either by the loss Notch or by prolonged 
FOXN1 overexpression, would extinguish TEPC bipotency and result in reduced 
mTEC cellularity. This regulatory node also helps to explain why, despite the early 
TEPC-like marker expression in constitutive NICD thymi, TECs eventually undergo 
some degree of differentiation (Chapter V). High Notch activity did not prevent these 
cells from expressing FOXN1 entirely, hence allowing them to eventually overcome 




















Chapter VII Concluding Remarks 
 
7.1 Summary of experimental results  
This thesis set out to examine the role of Notch signalling in regulating the early 
lineage divergence of TEC progenitors.  
In chapter III, I studied the expression of Notch pathway components in thymus 
organogenesis. The expression of Notch ligands DLL4 and JAG1, and Notch 
receptors NOTCH1, NOTCH2 and NOTCH3 were found in E12.5-14.5 TECs, as 
well as the canonical Notch targets.  
The functional relevance of Notch signalling in TEC development was investigated 
in chapter IV through Notch perturbation in TECs. Both genetic disruption and 
pharmacological inhibition showed that in the absence of Notch signalling, the 
development of the mTEC lineage is specifically affected. Using thymic tissue organ 
culture (FTOC), the significance of Notch activity in mTEC development was 
mapped precisely to between E10.5 and E16.5. The lack of Notch signalling in the 
very early primordium (E10.5 3PP) led to a drastic suppression of mTEC 
development, suggesting that Notch is required for the initial emergence of mTECs.  
These results raised the question as to whether mTEC specification per se is 
regulated by Notch, or the competence to become mTECs, which I addressed in 
chapter V with Notch gain-of-function analysis. Constitutive Notch activity primarily 
dictated an immature TEPC-like phenotype (K5+ K8+ PLET1hi MHCIIlow). Cortico-
medullary architecture was found to be disrupted, and persistent Notch activity 
resulted in a profound arrest of cTEC maturation, contradicting with an mTEC-
restricted role of Notch. Crucially, I found that constitutively active Notch signalling 
is permissive rather than instructive for mTEC development. Overall, these data 
suggest that Notch determines mTEC progenitor pool by controlling TEPC 
differentiation.  
In chapter VI, several targeted and unbiased approaches were taken to identify 
functional Notch targets and mechanisms underpinning the cellular behaviours in 
Notch loss- and gain-of-function models. While mTEC development is dependent on 
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both Notch and RANK signalling, the proliferation of specified mTECs mediated by 
RANK could occur despite the attempts to eliminate Notch. Their different temporal 
requirements indicate that the two pathways regulate independent checkpoints in 
mTEC development, and that Notch is temporally upstream of RANK. Furthermore, 
we studied the transcriptomes of Notch loss-of-function and gain-of-function TECs 
by RNA-seq. Bioinformatic analysis revealed that Notch exhibits a positive feedback 
loop to enhance its own activity. We have also identified a number of collagen genes 
and the EGFR pathway as potential functional targets downstream of Notch. Finally, 
we noted that the overexpression of FOXN1 in developing TECs produced a similar 
phenotype to the ablation of Notch. Gene expression data suggest a cross repressive 
relationship between Notch and FOXN1 in TEC differentiation.  
 
7.2 Conclusion 
Notch signalling is active in early fetal TECs. Abolishing or overexpressing Notch in 
TECs both resulted in aberrant TEC differentiation. The impact of Notch on mTEC 
development is limited to the earlier phase of TEC differentiation, and is distinct 
from RANK-facilitated mTEC proliferation and maturation. Transcriptomic analysis 
shed light on several potential mechanisms through which Notch may control TEC 
differentiation. Based on these data, an updated model of early TEC lineage 
regulation is proposed (Fig. 7): 
Notch activity in TEC progenitors appears to determine whether the bipotency of 
TEPCs is maintained or extinguished, with cTEC the preferred fate in premature 
differentiation. As the two sub-lineages emerge, Notch signalling is downregulated 
in cTECs but continues to be active in early mTECs, possibly as the result of positive 
feedback. Moreover, whilst Notch favours preserving primitive TEPCs, FOXN1 
promotes the differentiation of TECs in both mTEC and cTEC lineages. These two 
potent factors seem to antagonize each other, and their combined influence 
orchestrates the outcome of TEC differentiation. On the other hand, the emergence of 
mTECs can occur only in the presence of Notch, after which mTEC progenitors 
expand and mature through crosstalk with TNFSF ligands, including RANKL.  
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This updated model of TEC differentiation clarifies some previous uncertainties 
around the formation of cTEC and mTEC lineages. Although there is evidence for 
bipotent and unipotent TEC progenitors, their progenitor-progeny relationship was 
not well understood. Based on lineage tracing and developmental progression, it was 
proposed that bipotent TEPCs express mature cTEC markers β5t and CD205. From 
this an inference was made that TEPCs are phenotypically more closely related to the 
cTEC lineage, while mTEC specification probably requires input from additional 
signals (Alves et al., 2014). However, the cue for mTEC specification and the 
duration of TEPC bipotency were unclear. 
Our data suggest that Notch is required for the mTEC lineage, but it is unlikely to be 
the missing “specifier” that commits bipotent TEPCs to the mTEC fate. In fact, the 
results highlight the dependence of mTEC emergence on the maintenance of 
immature TEPCs. Precocious extinguishing of bipotency, brought about by Notch 
ablation or FOXN1 overexpression, appears to lead to the irreversible differentiation 
to the cTEC lineage, thereby exhausting cells with mTEC potential. Notwithstanding 
the caveats of the FTOC system, I have shown that this window of Notch sensitivity 
is limited to between E10.5 and E16.5, and this phase may reflect the approximate 
duration of TEPC bipotency in thymus development. The end stage of this estimate 
is earlier than that deduced from β5t lineage tracing (Mayer et al., 2015; Ohigashi et 
al., 2015), but the discrepancy may be due to the NFκB pathway (and mTEC 
expansion) increasingly outweighing the importance of Notch (and progenitor 
potency) on mTEC cellularity in late fetal stages. Nonetheless, given that Notch 
signalling is actively repressed in adult mTECs (Goldfarb et al., 2016), it makes 






















7.3 Future work 
Notch signalling is the result of ligand-receptor binding between adjacent cells. 
Experiments in this thesis focused on the effect of Notch activity levels on TEC 
differentiation. These approaches have been informative but were not conducive to 
uncover the source of Notch ligands activating TEC receptors. Enforced DLL1 on B 
cells or T cells enhances the number and organization of mTECs in a reaggregate 
culture system, pointing to DLL1 as a possible ligand. It is also noticeable that Notch 
signalling in TECs induces Jag1 expression, prompting a hypothesis where Notch 
can act in a lateral induction fashion among developing TECs, similar to the scenario 
regarding sensory cell development in the inner ear (Hartman et al., 2010).   
Our data and that of others indicate that Notch signalling is deployed differently in 
the early primordium and adult thymic epithelium. Goldfarb and colleagues have 
attempted to study the role of Notch in postnatal TECs with the NICD induction 
model used in this thesis (Goldfarb et al., 2016), but their interpretation was 
confounded by the absence of initial fetal phenotype analysis. A definitive 
investigation would require transgenic mice that enable the inducible manipulation of 
Notch activity. I am also intrigued by how the capacity for Notch signalling was 
modulated in fetal and adult thymi. One possibility is that the competence to receive 
Notch signal is regulated at the chromatin level. The invention of ATAC-seq 
(Buenrostro et al., 2013) has greatly reduced the number of cells required to generate 
a map of open chromatin. Comparing the chromatin states of adult TECs with fetal 
TECs would be informative in elucidating differential regulatory landscape at these 
developmental stages.  
In order to culture the thymic rudiments from younger embryos, an adapted FTOC 
system was developed in the thesis (Chapter IV). As this culture system can 
accommodate the growth of early primordia, it allows the interrogation of the 
signalling requirements of TEPCs. The behaviour of primitive TEPCs is the product 
of a multitude of signalling inputs. By utilizing this culture system, further work may 
reveal a more integrated picture of signals in the early thymic environment, and the 
precise effect of individual factors on the potency, proliferation and differentiation of 
various TEC progenitors.  
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This study focused on the TEC population-level responses to signalling stimuli. It 
would be of interest to tease out the effect of signalling at the single cell level. This is 
becoming more feasible thanks to rapid technological advances (reviewed in Hoppe 
et al., 2014). Many aspects related to TEC development may benefit from the 
transition from population to single cell analysis. It would facilitate the discovery of 
regulators that contribute to differential cellular behaviour and aid the identification 
of cell states hitherto indistinguishable by current characterization methods. 
Specifically, bipotent TEPCs and definitive cTECs share a number of markers, which 
rendered the interpretation of some data in this thesis difficult. Single cell analysis 
may uncover novel markers that allow the identification and tracking of the two cell 
states during organogenesis, and hence alter the assumptions made to reach 
conclusions in studies like this. It may also shed light on the missing mTEC 
“specifier” whose identity has thus far been elusive. 
Parallel to single cell transcriptomics, initial attempts to screen scaffold biomaterials 
suitable for supporting the growth and differentiation of TEPCs have been carried 
out in this laboratory. To date, rather than forming organoids, fetal TECs in culture 
tend to lose TEC-specific markers and degenerate, precluding the imaging of single 
TECs in a physiologically relevant context. Although several TEC cells lines have 
been established, their resemblance to in vivo TECs are not widely accepted. The 
development of complex culture systems that support thymic organoids will greatly 
benefit in vitro studies that can unveil dynamic cellular responses to 
microenvironmental changes, including to Notch. A particular interest to me is the 
role of collagen in modulating TEPC differentiation. Collagen genes are significantly 
upregulated in response to sustained Notch activity in TECs (Chapter VI). If the 
immature TEC phenotype we observed in the Foxn1Cre; Rosa26NICD model is partly 
down to increased presence of collagen in the thymus, we would expect to find 
evidence of delayed differentiation in organoids cultured in a collagen-rich scaffold.  
A long-term objective of this laboratory is to engineer thymic tissue that can 
reconstitute the adaptive immune system in immunodeficient or immunosenescent 
individuals (Bredenkamp et al., 2015). Realizing this goal would require a high 
degree of control in generating distinct subtype of stromal cells, or better, TEPCs 
capable of self-renewal. Despite the existing protocols to differentiate TECs from 
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pluripotent stem cells (Parent et al., 2013; Sun et al., 2013), or by direct conversion 
from fibroblasts (Bredenkamp et al., 2014b), cells generated from these procedures 
are highly variable, perhaps reflecting that the conditions in which these cells were 
produced are sub-optimal. The immediate potential of this study is therefore to 
improve, by manipulating Notch signalling, the efficiency of obtaining pure cortical, 
medullary or progenitor TEC populations. Furthermore, we have found potential 
mechanisms that may operate in tandem or against Notch in TEC development 
(Chapter VI). If confirmed experimentally, these mechanisms would further improve 



















Chapter VIII Appendices 
 
8.1 Gating strategies for flow cytometry 























































8.2 Data used for quantification in the thesis 
 
Figure 3.2-3.3 RT-qPCR results: normalized expression values 
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Figure 3.4 Percentage of E13.5 TECs expressing NOTCH1  
 
UEA1+ UEA1- 
Experiment 1  48.5 14.4 
Experiment 2  61 35.2 
Experiment 3  45 24.4 
 
Figure 3.5 Percentage of E14.5 TECs expressing Venus 
 
CD205+ UEA1+ MHCII+ MHCII- 
Sample 1 3.22 49.8 7.38 3.04 
Sample 2 4.97 53 10.8 4.08 
Sample 3 2.51 37.9 6.53 0.99 






Figure 4.2 Postnatal 14-day thymus 
(A) Percentage of mTECs in total TECs  
Male Control cKO 
Sample 1 78.8 63.8 
Sample 2 81.6 69.9 
Sample 3 78.6 67.3 
 
Female Control cKO 
Sample 1 55.9 42.7 
Sample 2 60.8 45.1 
Sample 3 58 42.7 
 
(B) Absolute cell number of TEC populations 
Male Total TEC mTEC mTEC hi mTEC low cTEC 
Control 1 39585.92 31198.7498 11687.63046 16979.86 5997.958 
Control 2 27323.42 22307.53736 9849.245851 10785.46 3424.454 
Control 3 25098 19738.91884 9275.164907 8770.536 3834.068 
cKO 1 9673.732 6169.184015 2260.298785 3454.222 2917.998 
cKO 2 9051.195 6296.552868 2617.829858 3210.682 2072.982 
cKO 3 8335.514 5613.950723 2587.925535 2656.488 2001.081 
 
Female Total TEC mTEC mTEC hi mTEC low cTEC 
Control 1 37955.88342 21220.07214 8385.721 11444.79 11589.85 
Control 2 51836.80138 31513.10974 12936.42 16840.4 14244 
Control 3 37653.90984 21825.35132 8766.791 11826.27 11791.74 
cKO 1 23519.52269 10034.0077 3028.142 6458.122 11820.75 
cKO 2 36264.06184 16360.83609 5467.659 10105.69 16842.81 






(C) Percentage of total thymocytes 
Female DN DP CD4+ SP CD8+ SP 
Control 1 5.21 87 5.62 2.15 
Control 2 5.98 88.3 2.82 2.88 
Control 3 4.73 87.1 5.75 2.39 
cKO 1 4.45 86 7.14 2.45 
cKO 2 4.97 88 4.68 2.38 
cKO 3 4.36 87.1 6.22 2.28 
 
Percentage of total DN thymocytes 
Female DN1 DN2 DN3 DN4 
Control 1 10.8 9.9 59.8 19.5 
Control 2 8.52 12.2 63.8 15.5 
Control 3 14.4 10.9 57.6 17.2 
cKO1 11.8 10.9 57.3 19.7 
cKO2 10.3 12 61 16.7 
cKO3 13.5 9.98 56 20.6 
 
(D) Treg cell number 
Male CD25- Foxp3+ CD25+ Foxp3- CD25+ Foxp3+ 
Control 1 164830.9 88840.13198 16717.97196 
Control 2 192749.9 192247.4739 34999.75788 
Control 3 170403.4 158298.862 31142.68629 
cKO 1 166069.1 188148.5966 30122.70071 
cKO 2 150220.6 110452.0649 26705.88691 








Figure 4.3  
(A) E14.5 K14 and UEA1 IHC 
Percentage of thymic sections positive for marker: 
K14+ Control cKO 
Sample 1 3.042215106 1.099275019 
Sample 2 5.716159645 2.120426332 
Sample 3 3.157568253 1.994872252 
Sample 4 3.125845985 1.760695401 
 
UEA1+ Control cKO 
Sample 1 0.762605376 0.178710457 
Sample 2 1.122594969 0.205559173 
Sample 3 0.867674665 0.271534197 
 
(B) E18.5: percentage of TECs expressing UEA1 
UEA1+ Control cKO 
Sample 1 10.9 4.8 
Sample 2 15.7 9.9 
Sample 3 13.7 5.74 
Sample 4 15.3 
 
Sample 5 16.4 
 
Sample 6 15.7 
 
Sample 7 19.8 
 
Sample 8 23 
 
Sample 9 20.9 
 
Sample 10 29.4 
 
Sample 11 33.4 
 
Sample 12 28.9 
 
Sample 13 25.8 
 
Sample 14 30.2 
 
Sample 15 29.7 
 




Sample 17 29.7 
 
Sample 18 31.9 
 
Sample 19 29.8 
 
Sample 20 41.1 
 
Sample 21 36.3 
 
 
(C) Postnatal 8-week: percentage of TECs expressing UEA1 
UEA1+ Control cKO 
Sample 1 80.4 75.8 
Sample 2 79.2 75 
Sample 3 77.3 84 
 
(D) Postnatal 16-week: percentage of TECs expressing UEA1 
UEA1+ Control cKO 
Sample 1 72 56.9 
Sample 2 76.8 59 
Sample 3 72.3 55.9 
 









Explant E12.5 Explant E12.5 Explant E12.5 
Experiment 1 2.004626 2.496661 0.035485 0.016289 1.558329 2.133664 
Experiment 2  4.313589 4.985637 0.010325 0.012382 3.307075 4.482938 
 
Figure 4.5 RT-qPCR results normalized expression values 
Hes1  Control PLET1-  Control PLET1+  DAPT PLET1-  DAPT PLET1+  
Experiment 1 1.139007919 1.670175839 0.507761256 1.191040294 






Figure 4.6  
(A) Percentage of mTECs in total TECs 
UEA1+ DMSO 1μm 10μM 20μM 
Experiment 1 12.8 7.2 6 6.1 
Experiment 2 14.1 10.2 7.9 6.1 
Experiment 3 9.3 5.9 N/A 2.7 
 
Cell number after FTOC of E12.5 lobes (total of 9 explants) 
 
Total TEC number mTEC number cTEC number 
 
DMSO 20μM DMSO 20μM DMSO 20μM 
Experiment 1 20050 15830 2566.4 965.63 16340.75 13582.14 
Experiment 2 26038 22783 3671.358 1389.763 20283.6 19843.99 
Experiment 3 22985 16925 2137.605 456.975 18365.02 14995.55 
 
(C) Percentage of mTECs in total TECs 
 
UEA1+ E12.5 E14.5 E16.5 
DMSO Experiment 1 12.8 23.1 29.4 
 
Experiment 2 14.1 19.6 23.8 
 
Experiment 3 9.27 17 23.7 
DAPT Experiment 1 6.08 11.8 37.3 
 
Experiment 2 6.05 13.6 22.1 
 
Experiment 3 2.68 9.01 21 
 
Figure 4.7 
Number of UEA1+ cells (total of 3 explants) 
UEA1+ cell number Experiment 1 Experiment 2 Experiment 3 
DMSO 68 110 80 
DMSO RANKL 70 93 78 
DAPT 14 10 5 




Number of CD205+ cells (total of 3 explants) 
CD205+ cell number Experiment 1 Experiment 2 Experiment 3 
DMSO 843 770 2148 
DMSO RANKL 608 453 724 
DAPT 591 627 1526 
DAPT RANKL 128 2171 1908 
 
Figure 5.1  
Percentage of GFP+ cells in total TECs 
E14.5 %GFP+ 
Sample 1 89.2 
Sample 2 91.5 
Sample 3 89.9 
Sample 4 91.9 
 
E16.5 %GFP+ 
Sample 1 92.5 
Sample 2 91.1 
Sample 3 91.4 
 
Figure 5.2 
Percentage of PLET1+ cells in total E14.5 TECs 
PLET1+ Control NICD 
Sample 1 71.7 95.8 
Sample 2 63.8 90.3 









Percentage of MHCII+ cells in total E14.5 TECs 
MHCII+ Control NICD 
Sample 1 40.4 18.9 
Sample 2 44.4 19.1 





Percentage of UEA1+ cells in total E14.5 TECs 
UEA1+ Control  NICD 
Sample 1 4.58 4.67 
Sample 2 4.04 4.73 






Control – 25 AIRE+ in 76 UEA1+ cells. 38.04 μm2 PLET1 positive staining in total 
area of 169 μm2. 
NICD – 25 AIRE+ in 77 UEA1+ cells. 145.13 μm2 PLET1 positive staining in total 
area of 169 μm2. 
 
Figure 5.4  
Percentage of UEA1+ cells in total E16.5 TECs 
UEA1+ Control NICD 
Sample 1 7.44 31.2 
Sample 2 5.34 44.5 
Sample 3 7.14 31.4 
 
Percentage of PLET1+ cells in total E16.5 TECs 
PLET1+ Control NICD 
Sample 1 22.5 64.4 
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Sample 2 28.5 81.5 
Sample 3 17 83 
 
Figure 5.5  
(A) Percentage of PLET1+ cells in E16.5 mTECs 
PLET1+ Control NICD 
Sample 1 36.3 62.5 
Sample 2 36.8 84 
Sample 3 35.5 81.3 
 
Percentage of MHCII+ cells in E16.5 mTECs 
MHCII+ Control NICD 
Sample 1 87.8 82.5 
Sample 2 89.6 74.3 
Sample 3 93.8 74 
 
(B) Percentage of PLET1+ cells in E16.5 cTEC/TEC progenitors 
PLET1+ Control NICD 
Sample 1 20.6 64.1 
Sample 2 27.1 77.4 
Sample 3 15 82.1 
 
Percentage of MHCII+ cells in E16.5 cTEC/TEC progenitors 
MHCII+ Control NICD 
Sample 1 78.7 49.6 
Sample 2 73.6 52.7 







Percentage of mTECs in total TECs  
UEA1+ dGuo RANKL RANKL+50μM DAPT 
Experiment 1 6.7 30.9 22.5 
Experiment 2 13.6 25.3 19.7 
Experiment 3 5.73 30.8 19.3 
 
Figure 6.2  
Percentage of mTECs in total TECs  
UEA1+ dGuo control dGuo cKO RANK control RANK cKO 
Sample 1 17.8 2.32 26.3 9.12 
Sample 2 10.1 3.21 39.7 7.31 
Sample 3 13.5 1.74 34.3 12.1 
Sample 4 13.4 2.6 26.8 8.69 
Sample 5 6.39 2 26 
 
Sample 6 6.23 
   
 
Percentage of MHCII+ cells in mTECs 
MHCII+ dGuo control dGuo cKO RANK control RANK cKO 
Sample 1 25.4 44.1 83.7 78.6 
Sample 2 40.7 65 76.9 70.7 
Sample 3 50.9 60 87.5 88.5 
Sample 4 43.2 43.3 83.1 93.2 
Sample 5 41.7 55.6 93.5 
 
Sample 6 29.9 
   
 
Percentage of MHCII+ cells in cTECs 
MHCII+ dGuo control dGuo cKO RANK control RANK cKO 
Sample 1 80.1 82.9 85.6 87.2 
Sample 2 70.7 75.9 71.3 55.6 
Sample 3 42.3 85.6 50.6 80.3 
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Sample 4 46.3 87.5 69 80.2 
Sample 5 68.8 83.5 73.4 
 
Sample 6 67.9 
   
 
Figure 6.3  
(A) Normalized Ascl1 expression (developmental pattern) 
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(B) Normalized Ascl1 expression (Rbpj cKO) 
Ascl1 Control PLET1- Control PLET1+ cKO PLET1- cKO PLET1+ 
Sample 1 0.281698195 0.289617809 0.07577038 0.02121327 
Sample 2 0.202750556 0.152947784 0.05615489 0.06672839 
Sample 3 0.216467482 0.200885375 0.1411749 0.02087294 
Sample 4 0.129408115 0.046070913 0.03910057 0.03280365 
Sample 5 0.112396317 0.020459134 0.05949404 0.05390888 
Sample 6 0.288504688 0.183858358 0.03227737 0.06918805 





Figure 6.4 RT-qPCR results: normalized expression values 
Notch1 Control PLET1- Control PLET1+ cKO PLET1- cKO PLET1+ 
Sample 1 0.014942 0.030867 0.012072 0.021312 
Sample 2 0.024937 0.050338 0.01322 0.02767 
Sample 3 0.028142 0.055853 0.019808 0.031346 
Sample 4 0.039464 0.050883 0.021295 0.02977 
Sample 5 0.021099 0.048773 0.01277 0.026278 
Sample 6 0.038119 0.038741 0.012575 0.016326 
Sample 7 0.021944 0.050532 0.009065 0.014433 
 
Notch2 Control PLET1- Control PLET1+ cKO PLET1- cKO PLET1+ 
Sample 1 0.619377 0.534238 0.453061 0.433602 
Sample 2 0.494638 0.538784 0.379513 0.465798 
Sample 3 0.61085 0.617471 0.473758 0.423699 
Sample 4 0.496546 0.41851 0.347078 0.326088 
 
Notch3 Control PLET1- Control PLET1+ cKO PLET1- cKO PLET1+ 
Sample 1 0.121021 0.284533 0.043485 0.067764 
Sample 2 0.14492 0.41626 0.050785 0.110338 
Sample 3 0.173139 0.430276 0.095612 0.119631 
Sample 4 0.125869 0.405189 0.0542 0.118166 
 
Jag1 Control PLET1- Control PLET1+ cKO PLET1- cKO PLET1+ 
Sample 1 0.273995 0.490465 0.194941 0.243914 
Sample 2 0.23129 0.577454 0.149916 0.230224 
Sample 3 0.249231 0.611791 0.253295 0.362096 
Sample 4 0.273573 0.445449 0.14492 0.218141 
Sample 5 0.33294 0.682494 0.174612 0.245989 
Sample 6 0.399611 0.819794 0.268563 0.343885 





Hes1 Control PLET1- Control PLET1+ cKO PLET1- cKO PLET1+ 
Sample 1 1.013179 0.967425 0.616046 0.506199 
Sample 2 1.048101 1.240663 0.501929 0.600587 
Sample 3 1.273579 1.314436 0.750308 0.916651 
Sample 4 1.081725 0.915945 0.573024 0.712025 
Sample 5 1.407694 2.506294 0.680919 1.079228 
Sample 6 1.693491 3.613341 0.735433 0.922316 
Sample 7 1.558329 3.89062 0.502703 0.978666 
 
HeyL Control PLET1- Control PLET1+ cKO PLET1- cKO PLET1+ 
Sample 1 0.160799 0.125289 0.040386 0.034674 
Sample 2 0.429283 0.425989 0.106006 0.065607 
Sample 3 0.41466 0.420448 0.137738 0.057645 
Sample 4 0.31498 0.376312 0.066883 0.046786 
 
Foxn1 Control PLET1- Control PLET1+ cKO PLET1- cKO PLET1+ 
Sample 1 6.660154 5.933523 6.443202 4.451972 
Sample 2 5.806939 3.813488 5.906167 5.031927 
Sample 3 5.718178 4.535027 3.307075 2.545198 
Sample 4 6.581121 4.14106 5.098243 4.189176 
Sample 5 7.568461 6.156977 7.271345 4.552524 
Sample 6 6.528116 5.762387 6.634556 5.181369 
 
Plet1 Control PLET1- Control PLET1+ cKO PLET1- cKO PLET1+ 
Sample 1 0.000908 0.076004 0.004948 0.076651 
Sample 2 0.007693 0.131924 0.003374 0.075596 
Sample 3 0.009611 0.149454 0.011832 0.113265 
Sample 4 0.020953 0.187722 0.011255 0.095612 
Sample 5 0.019415 0.263442 0.029678 0.219151 






8.3 RT-PCR products 
 
 
Figure 8.3 Agarose gel electrophoresis of RT-PCR products 
(A) Left to right: Hprt, Hmbs, Ywhaz, Foxn1, Tbx1, Il-7. 
(B) Left to right: Notch1, Notch2, Notch3, Jag1, Plet1, Hes1, Heyl, Hes6, 
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